tenofovir has been researched along with Hepatitis B in 338 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 53 (15.68) | 29.6817 |
2010's | 191 (56.51) | 24.3611 |
2020's | 94 (27.81) | 2.80 |
Authors | Studies |
---|---|
Aldern, KA; Almond, MR; Beadle, JR; De Clercq, E; Hostetler, KY; Korba, BE; Lampert, BM; Neyts, J; Painter, GR; Trost, LC | 1 |
Fu, L; Gao, F; Huang, S; Zhang, L; Zhao, S; Zhen, Y; Zhou, X | 1 |
Huang, X; Kallakury, BV; Kim, YW; Korolowicz, KE; Lee, KP; Li, B; Menne, S; Park, S; Suresh, M; Yon, C | 1 |
Chuang, WL; Dai, CY; Hsieh, MY; Huang, CF; Huang, CI; Huang, JF; Liang, PC; Nguyen, MH; Trinh, S; Yeh, ML; Yu, ML | 1 |
An, H; Byun, KS; Jung, YK; Kim, JH; Kim, TH; Lee, YS; Seo, YS; Um, SH; Yeon, JE; Yim, HJ; Yim, SY | 1 |
Ahn, SH; Chon, HY; Kim, SU; Kim, YJ; Lee, JH; Sinn, DH; Yoon, JH | 1 |
Chen, WC; Cheng, JS; Kao, SS; Li, YD; Li, YR; Lin, HS; Lu, CM; Sun, WC; Tsai, TJ; Tsai, WL; Tsay, FW; Wang, HM; Yin, CH | 1 |
Chen, L; Chen, X; Dai, E; Li, C; Li, S; Lv, X; Zhao, Z; Zhu, B | 1 |
Chang, SY; Chen, GJ; Hsieh, SM; Huang, SH; Huang, YC; Hung, CC; Liu, WC; Liu, WD; Sheng, WH; Su, LH; Su, YC; Sun, HY | 1 |
Chen, ZM; Cui, GL; Feng, YH; Huang, S; Li, GM; Li, GT; Li, J; Li, W; Li, WZ; Li, ZQ; Liang, HX; Lin, WB; Liu, N; Liu, YM; Lv, J; Pan, YJ; Song, N; Sun, CY; Wang, FS; Wang, M; Xu, GH; Xu, JH; Yu, ZJ; Zeng, QL; Zeng, YL; Zhang, DW; Zhang, GF; Zhang, GQ; Zhang, HX; Zhang, JY; Zhou, YH | 1 |
De Clercq, E | 4 |
Chang, IW; Chen, CY; Gaggar, A; Hsu, YC; Huang, YT; Lin, JT; Nguyen, MH; Pan, DZ; Podlaha, O; Suri, V; Tseng, CH; Wu, CY | 1 |
Barday, Z; Geragotellis, A; Naicker, V; Patel, S; Sanglay, L; Sonderup, M; Spearman, CW; Wearne, N | 1 |
Distenhreft, JIQ; Fioroti, CEA; Lacchine, K; Luchi, WM; Paulino, BB; Ramos, DR; Seguro, AC | 1 |
Kamiya, K; Kishimoto, M; Komine, M; Kuwahara, A; Morimoto, N; Ohtsuki, M; Sugai, J | 1 |
Anothaisintawee, T; Attia, J; Chaikledkaew, U; Chaiyakunapruk, N; McKay, GJ; Nguyen, HT; Phung, TL; Sobhonslidsuk, A; Talungchit, P; Thakkinstian, A; Thavorncharoensap, M | 1 |
Bai, G; Chen, Z; Gao, F; Guo, F; Li, X; Wang, H; Wang, X; Yuan, Y | 1 |
Barkema, HW; Coffin, CS; Samadi Kochaksaraei, G; Seow, CH; Shaheen, AA | 1 |
Hill, A | 1 |
Lampertico, P; Lim, YS | 1 |
Afdhal, NH; Ankoma-Sey, V; Bae, H; Curry, MP; Dieterich, D; Frazier, L; Frick, A; Hann, HW; Kim, WR; Kwo, P; Milligan, S; Pan, CQ; Reddy, KR; Tong, MJ | 1 |
Pan, CQ | 2 |
Cottrell, M; Crane, H; Di Girolamo, J; Dumond, J; Gane, E; Kashuba, A; Kayes, T; Levy, MT; Lim, TH; Manandhar, S; Symonds, A | 1 |
Arnouk, S; Dagher, NN; Feldman, DM; Papadopoulos, J; Park, JS; Stewart Lewis, Z; Whitsett, M | 1 |
Caroupaye-Caroupin, L; Chhim, K; Chhun, S; Dim, B; Durier, C; Ear, E; Fernandez, L; Guillebaud, J; Hout, K; Kim, R; Ky, V; Laurent, D; Meyer, L; Nem, B; Nhoueng, S; Pech, S; Rekacewicz, C; Ros, B; Segeral, O; Sovann, S; Vong, C; Yay, C; Yin, S; Yom, S | 1 |
Guo, XG; Huang, ZH; Liu, CW; Ou-Yang, S; Peng, TT; Yan, HZ; Yang, LL | 1 |
Bao, Z; Dong, H; He, Y; Hong, X; Mo, R; Shen, S; Wang, G; Zhang, J; Zhang, Y | 1 |
Chang, KC; Chang, MH; Chen, HL; Cheng, SW; Chiang, CL; Hsu, HY; Hu, JJ; Lai, MW; Lee, CN; Liu, CJ; Mu, SC; Ni, YH; Wen, WH; Wu, JF | 1 |
Kumar, M | 1 |
Gane, E; Kashuba, A; Levy, MT | 1 |
Ran, R; Wang, M; Zhang, H; Zhu, Y | 1 |
Boyd, A; Coffie, PA; Freedberg, KA; Hyle, EP; Kim, AY; Kouamé, MG; Larmarange, J; Mohareb, AM | 1 |
Lim, TO; Lim, ZZ; Tan, AC; Teo, JS | 1 |
Ahn, SH; Jung, CY; Kim, BS; Kim, HW; Kim, SU; Lee, HW; Lee, JI | 1 |
Hsiao, NY; Hu, NC; Joseph Davey, D; Mashele, N; Mvududu, R; Myer, L; Sonderup, M; Wendy Spearman, C | 1 |
Gartlehner, G; Harlfinger, J; Nußbaumer-Streit, B | 1 |
Béguelin, C; Bernasconi, E; Boillat-Blanco, N; Calmy, A; Günthard, HF; Hofmann, E; Rauch, A; Schmid, P; Stöckle, M; Surial, B; Suter-Riniker, F; Wandeler, G | 1 |
Adjei, G; Adu, F; Anyanful, A; Ephraim, RKD; Gavor-KWashi, C; Nsiah, P; Nyarko, SB; Thomford, NE | 1 |
Afdhal, NH; Chan, HLY; Chen, CY; Coffin, CS; Elkhashab, M; Fung, SK; Greenbloom, S; Iyer, RP; Jackson, K; Jang, JW; Jeng, WJ; Kim, DJ; Kim, W; Kim, YJ; Lee, KS; Lim, YS; Liu, CJ; Locarnini, SA; Macfarlane, C; Ramji, A; Yuen, MF | 1 |
Adekanle, O; Adeyemi, A; Anyabolu, C; Awowole, I; Ijadunola, M; Ijarotimi, O; Kuti, O; Makinde, O; Ndububa, D | 1 |
Baum, MM; Kiser, JJ; Thomas, DL | 1 |
Deng, Y; Pan, CQ; Park, J; Zhu, L | 1 |
Barreiro, P; Corral, O; Mendoza, C; Moreno-Torres, V; Soriano, V | 1 |
Hongfang, FU; Junli, Z; Xia, Z; Xiaoyu, HU; Ying, HE | 1 |
Chan, KM; Cheng, CH; Chou, HS; Hung, HC; Lee, CF; Lee, JC; Lee, WC; Wang, YC; Wu, TH; Wu, TJ | 1 |
Hwang, EG; Jung, EA; Kim, SG; Kim, YS; Yoo, JJ | 1 |
Chuan, L; Linye, H; Tianfu, W; Xiaoyun, Z; Zhihui, L; Zijing, X | 1 |
Cho, EJ; Jang, H; Kim, TM; Kim, YJ; Lee, HG; Lee, JH; Lee, YB; Yoon, JH; Yu, SJ | 1 |
Janekrongtham, C; Jantarapakde, J; Lertpiriyasuwat, C; Pan-Ngum, W; Poovorawan, K; Punsuwan, N; Tangkijvanich, P; Thitichai, P | 1 |
Cho, JY; Choi, D; Choi, Y; Hwang, S; Joo, DJ; Kang, KJ; Kim, BW; Kim, DG; Kim, DS; Kim, MS; Lee, JG; Nah, YW; Rhu, J; Ryu, JH; Yang, JD; You, YK | 1 |
Althoff, KN; Cachay, ER; Carbonari, DM; Chew, K; Coburn, SB; Gebo, KA; Gill, MJ; Horberg, MA; Hull, M; Kim, HN; Kim, J; Kirk, GD; Kitahata, MM; Klein, MB; Lang, R; Lim, JK; Lo Re, V; Mayor, AM; McGinnis, KA; Moore, RD; Napravnik, S; Newcomb, CW; Reddy, KR; Seaberg, EC; Silverberg, MJ; Sterling, TR; Torgersen, J | 1 |
Geng, H; Heng, H; Li, J; Liang, J; Liu, X; Zang, X | 1 |
Abdullah, T; Aydin, O; Çolak, M; Kinaci, E; Ocak, İ; Özcan, FG; Özden, İ; Poturoğlu, Ş | 1 |
Chandiwana, P; Duri, K; Gumbo, FZ; Marere, T; Mataramvura, H; Mazengera, LR; Mazhandu, AJ; Munjoma, PT | 1 |
Liu, S; Liu, Z; Ma, X; Xin, Y; Zhao, Z | 1 |
He, S; Wang, L; Wang, N; Zheng, Y | 1 |
Duan, YQ; Hu, P | 1 |
Li, C; Peng, W; Qi, W; Qi, X; Wen, T; Yi, M | 1 |
Gao, S; Gui, X; Ke, H; Xiong, Y; Yang, R | 1 |
Bhattacharya, D; Chihota, BV; Chilengi, R; Chung, RT; Egger, M; Mulenga, L; Vinikoor, MJ; Wandeler, G | 1 |
Huang, YS; Hung, CC; Ko, WC; Lee, YC; Lee, YT; Li, CW; Lin, JJ; Lin, KY; Lin, SP; Liu, CE; Tang, HJ; Wang, NC; Yang, HJ | 1 |
Bak, H; Byun, KS; Chang, SW; Hyun, MH; Jung, YK; Kim, JH; Kim, S; Lee, CU; Lee, HS; Lee, MJ; Lee, YS; Seo, YS; Um, SH; Yeon, JE; Yim, HJ | 1 |
He, D; Jiang, H; Jin, J; Li, S; Lin, N; Ma, Z; Wang, Y; Zhou, H | 1 |
Chen, K; Deng, H; Gao, H; Jiao, Q; Lei, Y; Li, H; Liang, S; Lin, L; Liu, H; Shi, Y; Xu, M; Zhuo, L | 1 |
Chen, G; Cui, F; Liang, P; Liang, X; Wang, F; Yin, J; Zhuang, G | 1 |
Pan, CQ; Wen, WH; Wong, GL | 1 |
Acar, Ş; Çakmak, E; Eminler, AT; Fidan, S; Hülagü, S; İskender, G; Koksal, AS; Sezikli, M; Şirin, G; Toka, B; Üsküdar, O; Uslan, MI; Yildirim, AE | 1 |
Chen, MB; Cui, WY; Wang, H; Xu, HL; Zheng, QH; Zheng, XW | 1 |
Burger, DM; Dams, K; Francque, S; Jorens, PG; Vanwolleghem, T; Weyler, J | 1 |
Amponsah-Dacosta, E; Blackard, JT; Burnett, RJ; Gededzha, MP; Kyaw, T; Lukhwareni, A; Mphahlele, MJ; Selabe, SG | 1 |
Huang, J; Lin, S; Wang, M; Zhang, K; Zhu, Y | 1 |
Chang, KC; Chang, MH; Chen, HL; Chiang, CL; Hsu, HY; Lai, MW; Lee, CN; Lin, LH; Mu, SC; Ni, YH; Wen, WH; Wu, JF; Zhao, LL | 1 |
Cai, WP; Deng, XZ; Hu, FY; Lan, Y; Li, F; Li, LH; Nie, Y | 1 |
Angkurawaranon, C; Bierhoff, M; Ehrhardt, S; McGready, R; Nosten, F; Pimanpanarak, M; Rijken, MJ; Thio, CL; van Vugt, M; Yotyingaphiram, W | 1 |
Béguelin, C; Bernasconi, E; Boillat-Blanco, N; Chave, JP; Doco-Lecompte, T; Fehr, J; Furrer, H; Günthard, HF; Rauch, A; Schmid, P; Stöckle, M; Surial, B; Walti, LN; Wandeler, G | 1 |
Angkurawaranon, C; Bierhoff, M; Carrara, V; Ehrhardt, S; Guo, N; Jia, Y; Jittamala, P; Ling, C; McGready, R; Nelson, KE; Nosten, F; Rijken, M; Thio, CL; Tongprasert, F; van Vugt, M; Watthanaworawit, W | 1 |
Bukkems, VE; Burger, DM; Colbers, AP; Cressey, TR; Jourdain, G; Smolders, EJ | 1 |
Chan, HLY; Gaggar, A; Ganova-Raeva, L; Khudyakov, Y; Kitrinos, K; Lara, J; Thai, H; Xia, GL; Xu, X | 1 |
Baba, M; Furuya, K; Kawagishi, N; Kimura, M; Kitagataya, T; Maehara, O; Miyoshi, H; Morikawa, K; Nakai, M; Nakamura, A; Natsuizaka, M; Ogawa, K; Ohara, M; Ohnishi, S; Sakamoto, N; Shigesawa, T; Sho, T; Suda, G; Suzuki, K; Yamada, R; Yamamoto, K; Yamamoto, Y | 1 |
Michler, T; Protzer, U; Velkov, S | 1 |
Ostankova, YV; Semenov, AV; Serikova, EN; Totolian, AA; Zueva, EB | 1 |
Shen, M; Sun, X; Wang, B; Wang, C; Xu, H; Yang, X; Zhu, K | 1 |
Chen, ZM; Cui, GL; Ji, F; Li, GM; Li, J; Li, W; Li, ZQ; Liang, HX; Liu, YM; Lv, J; Pan, YJ; Sun, CY; Wang, FS; Xu, JH; Yu, ZJ; Zeng, QL; Zhang, DW; Zhang, GF | 1 |
Bai, L; Chen, B; He, S; He, X; Hu, M; Liu, D; Liu, F; Luo, H; Luo, R; Ma, J; Song, X; Xie, Y; Yang, Y; Yao, D; Ye, T; Zhang, Z | 1 |
Chan, HL | 1 |
Enomoto, M; Kawada, N; Nishiguchi, S; Tamori, A; Yoshida, K | 1 |
Angkurawaranon, C; Bierhoff, M; Devine, A; Kobphan, P; McGready, R; Nosten, FN; Rijken, MJ; Sriprawa, K; van Vugt, M | 1 |
Cholongitas, E; Orfanidou, A; Papatheodoridis, GV | 1 |
Chan, P; Cui, F; Fuzhen, W; Guomin, Z; Hallett, TB; Hui, Z; Nayagam, S; Ning, M; Thursz, M; Xiaojin, S; Zundong, Y | 1 |
Byun, KS; Choi, J; Gwak, GY; Kim, JH; Kim, YJ; Kwon, SY; Lee, HC; Lee, YS; Lim, YS; Yoo, BC | 1 |
Chang, SH | 1 |
Bhat, R; Dash, R; Jayaram, B; Kiruthika, S; Rathore, AS; Vivekanandan, P | 1 |
Barnes, E; Campbell, C; Collier, J; Cripps, S; Davies, J; Freeman, O; Jeffery, K; Matthews, PC; McNaughton, AL; Mokaya, J; Noble, T; Salih, H; Smith, DA; Várnai, KA; Wang, T; Woods, K | 1 |
Busca Arenzana, C; Daroca, G; Martin-Carbonero, L; Mican, R; Perez-Valero, I; Vasquez, J | 1 |
Khamadi, SA; Lihana, RW; Mabeya, SN; Ngugi, C; Nyamache, AK | 1 |
Brouwer, WP | 1 |
Brousseau, N; Gilca, V; Larouche, J; Mandal, S; Murphy, DG; Tedder, RS | 1 |
Abdul Hafidz, MI; Lee, YY; Tan, SS | 1 |
Gore, ML; Jatta, A; Lemoine, M; Ndow, G; Njie, R; Sabally, S; Sadiq, F; Shimakawa, Y; Sow, A; Suso, P; Tamba, S; Thursz, MR; Touré-Kane, C | 1 |
Choi, HS; Jun, DW; Jung, TY; Lee, HL; Lee, KN; Lee, OY; Yoon, BC | 1 |
Chen, JQ; Chen, JZ; Cheng, XY; Huang, FL; Huang, Z; Liao, ZW; Liu, JQ; Su, RK; Wang, WB | 1 |
Abraham, I; Chacra, W; Danciu, OC; Kankanala, V; Remo, M | 1 |
Lau, JSY; Ratnam, D; Woolley, I | 1 |
Byun, KS; Hyun, MH; Kim, JH; Lee, YS; Yeon, JE | 1 |
Ahir, BK; Li, LQ; Wu, GB; Zhang, CY; Zhong, JH | 1 |
Akpomiemie, G; Arulappan, N; Chersich, MF; Majam, M; Mashabane, N; Moorhouse, M; Venter, WDF | 1 |
Forde, KA; Kaplan, DE; Serper, M | 1 |
Agarwal, A; Alexander, PE; Chang, Y; Foroutan, F; Guyatt, GH; Hepworth, E; Lee, Y; Lesi, O; Mah Ming, J; Merglen, A; Mir, H; Mirza, R; Siemieniuk, RA; Zeraatkar, D; Zhang, Y | 1 |
Buti, M; Calleja, JL; Castillo, P; Esteban, R; García-Retortillo, M; Gómez Rubio, M; Gutiérrez, ML; López, J; Manzano, ML; Martín, L; Morano, LE; Morillas, RM; Prieto, M; Rodríguez, M; Simón, MA; Suárez, E; Yébenes, M; Zozaya, JM | 1 |
Avihingsanon, A; Bloch, M; Cahn, P; East, L; Homony, B; Kaplan, R; Katlama, C; Leavitt, R; Molina, JM; Nguyen, BY; Rassool, M; Ratanasuwan, W; Rawlins, S; Rodgers, A; Rojas, E; Ruane, P; Sax, PE; Sklar, P; Squires, K; Teppler, H; Vandekerckhove, L; Wenning, L; Xu, X; Yazdanpanah, Y | 1 |
Cathcart, AL; Delaney, WE; Kitrinos, KM; Liu, Y | 1 |
Hendren, N; Hofmann, S; Moore, J; Rambally, S | 1 |
Bhatia, R; Dash, D; Elavarasi, A; Tripathi, M | 1 |
Burman, BE; Jhaveri, MA; Kowdley, KV | 1 |
Endo, T; Ito, K; Saitoh, S; Sugiura, T; Suzuki, M; Tajiri, H; Tanaka, Y; Wakano, Y | 1 |
Asriel, B; Chan, L; Eaton, EF; Wyatt, CM | 1 |
Jhaveri, R; Meshnick, SR; Parr, JB; Wilson, P | 1 |
Padma, UD; Surendran, S; Udayakumar, VP | 1 |
Achalapong, J; Bowonwatanuwong, C; Buranabanjasatean, S; Chakhtoura, N; Chotivanich, N; Chung, RT; Cressey, TR; Decker, L; Harrison, L; Jourdain, G; Kanjanavikai, P; Khamduang, W; Klinbuayaem, V; Liampongsabuddhi, P; Limtrakul, A; Matanasarawut, W; Murphy, TV; Na Ayudhaya, OP; Nelson, NP; Ngo-Giang-Huong, N; Pol, S; Prommas, S; Puernngooluerm, P; Puthanakit, T; Putiyanun, C; Sabsanong, P; Salvadori, N; Sangsawang, S; Siberry, GK; Sirirungsi, W; Siriwachirachai, T; Suriyachai, P; Thanprasertsuk, S; Thongsawat, S; Tierney, C; Varadisai, S; Watts, DH; Yuthavisuthi, P | 1 |
Becquet, V; Danel, C; Eholié, S; Larmarange, J; Masumbuko, JM; Nouaman, M; Plazy, M | 1 |
Dickson, I | 1 |
Abdou Chekaraou, M; Anglaret, X; Boyd, A; Danel, C; Delaugerre, C; Eholié, SP; Gabillard, D; Lacombe, K; Mahjoub, N; Maylin, S; Moh, R; Zoulim, F | 1 |
Appiah, LT; Beloukas, A; Chadwick, D; Geretti, AM; Phillips, RO; Post, F; Ruggiero, A; Sarfo, FS; Smith, C; Stockdale, AJ; Villa, G | 1 |
Agarwal, K; Bruce, M; Carey, I; Considine, A; Heaton, N; Heneghan, M; Lampertico, P; Lim, TY; Manini, MA; Passerini, M; Suddle, A; Whitehouse, G | 1 |
Andersson, MI; Arends, JE; Glashoff, RH; Maponga, TG; Preiser, W; Taljaard, J; van Rensburg, CJ | 1 |
Agarwal, K; Ahn, SH; Bae, H; Bhardwaj, N; Brunetto, M; Buti, M; Cathcart, AL; Çelen, MK; Chan, HLY; Chuang, WL; Flaherty, JF; Fung, S; Furusyo, N; Gaggar, A; Gane, EJ; Izumi, N; Janssen, HLA; Lau, AH; Lim, YS; Lin, L; Mani Subramanian, G; Marcellin, P; Pan, CQ; Seto, WK; Shalimar, D; Sharma, M; Suri, V; Trinh, H; Yoon, KT | 1 |
Chan, P; Cui, F; Woodring, J; Xu, F | 1 |
Akbulut, S; Harputluoglu, M; Yilmaz, S | 1 |
Harrison, L; Jourdain, G; Ngo-Giang-Huong, N | 1 |
Feld, JJ; Lok, ASF; Terrault, NA | 1 |
Gerlich, W; Glebe, D | 1 |
Cheung, KW; Ng, EHY; Seto, MTY | 1 |
Alkım, C; Alkım, H; Colak, T; İyisoy, MS; Karayakar, F; Koksal, AR; Sahin, M; Şen, İ; Yetim, A | 1 |
Alsunaid, SR; Ashraf, H; Soubani, AO | 1 |
Jiang, XW; Li, LJ; Li, YT; Ye, JZ | 1 |
Bulterys, M; Chen, L; Fan, B; Kourtis, AP; Liu, W; Shepard, C; Shepherd, JA; Wang, A; Wang, L; Wiener, J | 1 |
Chao, Y; Hou, MC; Huang, YH; Lan, KH; Lee, IC; Li, CP; Lin, HC; Su, CW | 1 |
Goyal, A; Romero-Severson, EO | 1 |
Jiang, X; Luo, A; Ren, H | 1 |
Chen, QY; Fang, ZL; Harrison, TJ; Hu, LP; Jia, HH; Li, KW; Liang, SJ; Ren, CC; Wang, C; Wang, XY; Yang, QL | 1 |
Aslam, A; Ishtiaq, R; Lau, DTY | 1 |
Chan, HLY | 1 |
Naing, C; Poovorawan, Y; Tong, KS | 1 |
Szeto, CC; Wong, GL; Wong, VW | 1 |
Bian, Q; Chang, L; Li, R; Pan, CQ; Pang, Q; Tiongson, BC; Wang, M; Zhang, H; Zhu, Y | 1 |
Andersson, M; Eilard, A; Lindh, M; Norkrans, G; Ringlander, J; Wejstål, R | 1 |
Brancaccio, G; Fasano, M; Gaeta, GB; Grossi, A; Santantonio, TA | 1 |
Jindal, A; Vyas, AK | 1 |
Hassan, M; Lim, N; Singh, D | 1 |
Duff, P; Sylvester-Armstrong, KR | 1 |
Bulterys, M; Cressey, TR; Decker, L; Fan, B; Harrison, L; Jourdain, G; Khamduang, W; Kourtis, AP; Luvira, A; Ngo-Giang-Huong, N; Phanomcheong, S; Puangsombat, A; Putiyanun, C; Salvadori, N; Shepherd, JA; Siberry, GK; Srirompotong, U; Suwannarat, A; Teeyasoontranon, W; Tierney, C | 1 |
Li, H; Zeng, J; Zheng, C | 1 |
Atkinson, A; Bernasconi, E; Bonnet, F; Dabis, F; Dufour, JF; Fehr, J; Gjærde, LK; Kraus, D; Mauron, E; Neau, D; Peters, L; Rauch, A; Reiss, P; Rockstroh, J; Smit, C; van der Valk, M; Wandeler, G | 1 |
Amanda, TO; Kpossou, AR; Séhonou, J; Sokpon, CNM; Vigan, J; Vignon, RK | 1 |
Wahid, B | 1 |
Andersson, M; Barnes, EJ; Burn, EAO; Goedhals, D; Matthews, PC; Mokaya, J; Pinedo-Villanueva, R; Tamandjou, CR | 1 |
Abdool Karim, SS; Baxter, C; Blackard, JT; Ngcapu, S; Penton, PK; Powell, EA | 1 |
Colmenero, J; Forns, X; Gómez-Hernando, M; Llach, J | 1 |
Archampong, T; Bears, K; Chen, Y; Gong, Y; Kwara, A; Langaee, T; Lartey, M; Obo-Akwa, A; Ojewale, O; Sagoe, KW | 1 |
Hu, X; Wang, L; Xu, F | 1 |
Fan, LW; Ma, YL; Zhao, C | 1 |
Pan, CQ; Zhang, H | 1 |
Gatanaga, H; Hayashida, T; Oka, S; Tanuma, J | 1 |
Brown, RS; Chang, MS; Emond, JC; Guarrera, JV; Heese, S; Olsen, SK; Pichardo, EM; Stiles, JB | 1 |
Brown, RS; Brubaker, WD; Chang, MS; Emond, JC; Guarrera, JV; Olsen, SK; Pichardo, EM; Rosenthal-Cogan, L; Stiles, JB | 1 |
Arberas-Díez, B; Casals-Seoane, F; García-Buey, L | 1 |
Angeletti, C; Antonucci, G; Armignacco, O; Cassola, G; De Stefano, G; Girardi, E; Grossi, P; Mazzotta, F; Orani, A; Pagano, G; Petrosillo, N; Puoti, M; Sagnelli, C; Sagnelli, E | 1 |
Abouljoud, MS; Bajjoka, IE; McGonigal, KH | 1 |
Goyal, N; Gupta, S; Kumar, A; Taneja, S; Wadhawan, M | 1 |
Feng, J; Hang, TJ; Jia, YY; Lu, CT; Song, Y; Sun, Y; Wang, S; Wen, AD; Yang, ZF; Zhao, JY | 1 |
Bani-Sadr, F; de Vries-Sluijs, T; Dunn, D; Gilson, R; Jain, MK; Kuzushita, N; Mauss, S; Nüesch, R; Núñez, M; Peters, M; Pillay, D; Price, H; Reiberger, T; Stephan, C; Tan, L | 1 |
Gulland, A | 1 |
Botes, ME; Hamers, RL; Hoepelman, AI; Ive, P; Rinke de Wit, TF; Sigaloff, KC; Siwale, M; Stevens, WS; Wallis, CL; Zaaijer, HL | 1 |
Kitrinos, KM; Liu, Y; Miller, MD | 2 |
Calvaruso, V; Craxì, A | 1 |
Ay, M; Ayaz, C; Barcin, T; Celen, MK; Dal, MS; Dal, T; Gulsun, S; Kalkanli, S; Kaya, S; Mert, D; Yildirim, N | 1 |
Chung, RT; Fishman, JA; Wright, AJ | 1 |
Amorosa, VK; Chang, KM; De La Torre, P; Frank, I; Gross, R; Hafkin, JS; Kostman, JR; Lo Re, V; Localio, AR; Mounzer, K; Osborn, MK; Stern, JJ | 1 |
Becker, CB; Hamnvik, OP; Levy, BD; Loscalzo, J | 1 |
Aberg, JA; Hollabaugh, K; Kang, M; Koletar, SL; Pham, V; Smurzynski, M; Wu, K | 1 |
Coppola, N; Filippini, P; Martini, S; Pisaturo, M; Sagnelli, C; Sagnelli, E | 1 |
Chatterjee, U; Davison, S; Glass, A; Greenup, AJ; Holdaway, S; Jackson, K; Levy, MT; Locarnini, SA; Nguyen, V; Samarasinghe, D; Tan, PK | 1 |
Rao, W; Shen, Z; Xie, M | 1 |
Bartholomew, ML; Chang, A; Tsai, N; Tsai, PJ; Yamada, S | 1 |
Lampertico, P; Mangia, G; Viganò, M | 1 |
Abe, M; Hiasa, Y; Hirooka, M; Ikeda, Y; Koizumi, Y; Kumagi, T; Matsuura, B; Ochi, H; Tada, F; Takada, K; Tokumoto, Y; Watanabe, T | 1 |
Roche, B; Samuel, D | 1 |
Adamidi, S; Alexopoulou, A; Deutsch, M; Koskinas, JS; Manolakopoulos, S; Pectasides, D; Skondra, M; Tampaki, M | 1 |
James, G; Raza, M; Sidhu, P | 1 |
Ehrhardt, S; Guo, N; Nelson, K; Thio, CL; Xie, C | 1 |
Hamada-Tsutsumi, S; Imamura, J; Sugiura, W; Tanaka, Y; Watanabe, T; Yokomaku, Y | 1 |
Furusyo, N; Hayashi, J; Hiramine, S; Mitsumoto, F; Murata, M; Ogawa, E; Shimizu, M; Takayama, K; Toyoda, K; Ura, K | 1 |
Akarsu, M; Astarcıoğlu, İ; Hakim, GD; Karademir, S; Unek, T | 1 |
Choudhary, NS; Goja, S; Menon, PB; Mohanka, R; Rastogi, A; Saigal, S; Saraf, N; Soin, AS | 1 |
Chen, WD; Gong, GZ; Luo, Y; Zhou, HY | 1 |
Alvey, N; Chan, EY; Cohen, E; Eswaran, S; Fayek, SA; Fleetwood, VA; Hertl, M; Shah, N; Singer, GA; Zielsdorf, S | 1 |
Aktas, B; Aktürk, T; Basyigit, S; Nazligul, Y; Yılmaz, B | 1 |
Ahmadinejad, Z; Dashti, H; Jafarian, A; Kasraianfard, A; Moini, M; Najafi, A; Nassiri-Toosi, M; Salimi, J | 1 |
Fong, TL; Hsieh, MJ; Khemichian, S; Kim, J; Limurti, J; Zhang, SR | 1 |
Ariaudo, A; Bonora, S; Calcagno, A; Carcieri, C; D'Avolio, A; De Nicolò, A; Di Perri, G; Sciandra, M; Simiele, M | 1 |
Akıncı, H; Balık, İ; Başar, Ö; Çoban, Ş; Dökmeci, A; Güner, R; Kalkan, Ç; Örmeci, N; Özbaş, B; Özkan, H; Yalçı, A; Yüksel, İ; Yüksel, O | 1 |
Boettiger, DC; Chaiwarith, R; Choi, JY; Ditangco, R; Durier, N; Kamarulzaman, A; Kantipong, P; Kerr, S; Kiertiburanakul, S; Kumarasamy, N; Law, M; Lee, CK; Li, PC; Merati, TP; Mustafa, M; Ng, OT; Oka, S; Pham, TT; Pujari, S; Ratanasuwan, W; Van Kinh, N; Vonthanak, S; Wong, WW; Yunihastuti, E; Zhang, F | 1 |
Battegay, M; Bernasconi, E; Bihl, F; Calmy, A; Caminada, AP; Cavassini, M; Ledergeber, B; Martinetti, G; Rickenbach, M; Vernazza, P; Wandeler, G; Weber, R | 1 |
Cao, F; Chen, T; He, Y; Jin, L; Liu, J; Qi, C; Wang, J; Yan, T; Yang, Y; Zhang, S; Zhao, Y | 1 |
Aleman, J; de Fijter, CW; Franssen, EJ; van den Berk, GE | 1 |
Abradelo, M; Calvo, J; Cambra, F; Castellano, G; Fernández, I; García, A; Hernández, O; Jiménez, C; Loinaz, C; Manrique, A; Manzano, M | 1 |
Anglaret, X; Boyd, A; Danel, C; Delaugerre, C; Eholié, SP; Gabillard, D; Girard, PM; Lacombefor, K; Mahjoub, N; Maylin, S; Moh, R; Zoulim, F | 1 |
Chu, CK; Konreddy, AK; Rawal, RK | 1 |
Habib, G; Nashashibi, M | 1 |
Castillo, E; Coffin, CS; Gao, S; Lee, SS; Martin, SR; Osiowy, C; Simmonds, K; van Marle, G; Virine, B; Wang, T | 1 |
Almeida, JR; Esberard, EB; Lopes, PF; Lugon, JR; Medeiros, T; Mendes, GF; Patricio, JA; Silva, AA | 1 |
Sonderup, MW; Spearman, CW; Suter, J | 1 |
Aliosmanoglu, I; Cetinkaya, R; Erbis, H; Kocak, H; Suleymanlar, G; Ulger, BV; Yilmaz, VT | 1 |
Du, S; Guo, F; Han, Y; Li, T; Li, Y; Lv, W; Qiu, Z; Song, X; Thio, CL; Wang, H; Wang, N; Xie, J; Zhu, T | 1 |
Archampong, TN; Boamah, I; Flanigan, T; Gillani, FS; Kenu, E; Kwara, A; Lartey, M; Obo-Akwa, A; Sagoe, KW; Yang, H | 1 |
Anderson, PL; Kiser, JJ; Lan, A; Naggie, S; Patel, K; Tillman, H; Wong, TC | 1 |
Suzuki, Y | 1 |
Chauhan, R; Kumar, M; Rooge, S; Sarin, SK; Singh, AK; Varshney, A | 1 |
Benson, P; Brinson, C; Brunetta, J; Cheng, A; Crofoot, G; Das, M; Fordyce, M; Gallant, J; Garner, W; McCallister, S; Mills, A; Oka, S | 1 |
Battegay, M; Bernasconi, E; Braun, DL; Darling, K; Günthard, HF; Hirzel, C; Hoffmann, M; Kouyos, RD; Kovari, H; Marzel, A; Rougemont, M; Scherrer, AU; Shilaih, M | 1 |
Boyd, A; Delaugerre, C; Girard, PM; Lacombe, K; Lascoux-Combe, C; Lavocat, F; Maylin, S; Miailhes, P; Zoulim, F | 1 |
Achalapong, J; Bowonwatanuwong, C; Chotivanich, N; Chung, RT; Cressey, TR; Decker, L; Harrison, L; Hongsiriwon, S; Hua, L; Jourdain, G; Khamduang, W; Klinbuayaem, V; Murphy, TV; Ngo-Giang-Huong, N; Pol, S; Puthanakit, T; Salvadori, N; Siberry, GK; Sirirungsi, W; Thongsawat, S; Tierney, C; Traisathit, P; Watts, DH | 1 |
Mathew, JL | 1 |
Gupta, B | 1 |
Chawla, D | 1 |
Antinori, S; Binda, F; Cattaneo, D; Cheli, S; Falvella, FS; Gervasoni, C; Mazzali, C; Milazzo, L; Ronzi, P; Sollima, S | 1 |
Bénifla, JL; Berçot, B; Bergmann, JF; Chopin, D; Delcey, V; Evans, J; Lopes, A; Maylin, S; Sellier, PO; Simon, F; Simoneau, G | 1 |
Dittmer, U; Esser, S; Jochum, C; Storim, J; Streeck, H; Timm, J; Verheyen, J | 1 |
Aurpibul, L; Bunupuradah, T; Hansudewechakul, R; Kanjanavanit, S; Kosalaraksa, P; Lumbiganon, P; Puthanakit, T; Taeprasert, P | 1 |
Chang, SC; Chang, SY; Chuang, YC; Huang, YS; Hung, CC; Lee, KY; Liu, WC; Sheng, WH; Su, YC; Sun, HY | 1 |
Ahmed, KN; Hafeez, M; Khan, RG; Rafe, A; Rasool, G; Sarfraz, T | 1 |
Arcaini, L; Gotti, M; Merli, M; Rattotti, S | 1 |
Masoumy, EP; Stansfield, BK | 1 |
Amanzada, A; Bremer, SCB; Eiffert, H; Ellenrieder, V; Neesse, A; Reinhardt, L; Ströbel, P; Wulf, G | 1 |
Calabresi, A; Carosi, G; Cologni, G; Costarelli, S; Lapadula, G; Puoti, M; Quiros-Roldan, E; Tirelli, V; Torti, C; Zaltron, S | 1 |
Amin, J; Avihingsanon, A; Bowden, S; Cooper, DA; Dore, GJ; Lewin, SR; Locarnini, S; Marks, P; Matthews, GV; Petcharapirat, P; Rerknimitr, R; Ruxrungtham, K; Sasadeusz, J | 1 |
Boelle, PY; Bonnard, P; Boyd, A; Girard, PM; Gozlan, J; Lacombe, K; Lascoux-Combe, C; Miailhes, P; Molina, JM; Serfaty, L; Zoulim, F | 1 |
Beckebaum, S; Cicinnati, VR; Gerken, G; Sotiropoulos, GC | 1 |
Barreiro, P; García-Samaniego, J; Martín-Carbonero, L | 1 |
Avihingsanon, A; Bowden, S; Dore, GJ; Lewin, SR; Locarnini, SA; Marks, P; Matthews, G; Perelson, AS; Ribeiro, RM; Ruxrungtham, K | 1 |
Arrifin, N; Audsley, J; Ayres, A; Bartholomeusz, A; Crowe, SM; Lewin, SR; Locarnini, SA; Mijch, A; Sasadeusz, J; Yuen, LK | 1 |
Alvarez-Uria, G; Ratcliffe, L; Vilar, J | 1 |
Baumert, TF; Doffoel, M; Fafi-Kremer, S; Gut, JP; Habersetzer, F; Pastor, R; Schvoerer, E; Stoll-Keller, F | 1 |
Amini-Bavil-Olyaee, S; Herbers, U; Luedde, T; Sheldon, J; Tacke, F; Trautwein, C | 1 |
Barisani, T; Geusau, A; Jalili, A; Kinaciyan, T; Peck-Radosavljevic, M; Stingl, G; Wöhrl, S | 1 |
Angus, PW; Patterson, SJ | 1 |
Abdel Razek, W; Belghiti, J; Durand, F; Francoz, C; Lada, O; Marcellin, P; Moucari, R; Valla, D | 1 |
Atkins, M; Fisher, M; Gilleece, Y; Grover, D; Mandalia, S; Murungi, A; Nelson, M; Tan, LK | 1 |
de la Loma, GA; Mateos Lindemann, M; Moreira Vicente, V; Rodríguez Dominguez, M | 1 |
Bourgeois, A; Calmy, A; Ciaffi, L; Delaporte, E; Ducos, J; Kouanfack, C; Koulla-Shiro, S; Laurent, C; Mougnutou, R; Mpoudi-Ngolé, E; Nkoué, N | 1 |
Taéron, C | 1 |
Abgueguen, P; Calès, P; Ducancelle, A; Gordien, E; Le Gal, F; Le Guillou-Guillemette, H; Lunel, F; Mansour, W; Pivert, A | 1 |
Berg, T; Böcher, WO; Buggisch, P; de Man, RA; Deterding, K; Erhardt, A; Feucht, HH; Hüppe, D; Möller, B; Petersen, J; Reinders, JG; Rhode, P; Sarrazin, C; Spengler, U; Stein, K; Trojan, J; van Bömmel, F; Wasmuth, HE; Wedemeyer, H; Wiedenmann, B | 1 |
Gervain, J; Horváth, G; Hunyady, B; Makara, M; Pár, A; Szalay, F; Telegdy, L; Tornai, I | 1 |
Chee, GM; Poordad, F | 1 |
Jiang, L; Yan, LN | 1 |
Lok, AS | 1 |
Coffin, CS; Michalak, TI; Mulrooney-Cousins, PM; Peters, MG; Roberts, JP; Terrault, NA; van Marle, G | 1 |
Gianini, RJ; Gomes-Gouvêa, MS; Leite, OM; Locarnini, S; Martins, LG; Mendes-Correa, MC; Pinho, JR; Santana, RA; Silva, MH; Sitnik, R; Uip, DE; Yuen, L | 1 |
de la Cruz-Lombardo, J; Jiménez-Pérez, M; Lozano-Rey, JM; Mongil Poce, L; Rodrigo-López, JM; Sáez-Gómez, AB | 1 |
Brost, S; Eisenbach, C; Schnitzler, P; Stremmel, W | 1 |
Christodoulou, DK; Katsanos, KH; Tsianos, EV; Tsianos, VE; Vagias, I; Zervou, E; Zioga, H; Zois, CD | 1 |
Bartels, M; Berg, T; Hartmann, J; Jonas, S; Karlas, T; Maier, M; Mössner, J; Tillmann, HL; Weimann, A; Wiegand, J | 1 |
Mallet, V; Pol, S; Vallet-Pichard, A | 1 |
Andersen, ES; Christensen, PB; Frigstad, SO; Kjær, M; Konopski, Z; Krarup, H; Leutscher, P; Moessner, B; Weiland, O; Weis, N; Westin, J | 1 |
Alterio, A; Comparcola, D; Corsetti, T; de Ville de Goyet, J; Diamanti, A; Iacono, A; Nobili, V; Pizzichemi, G; Sartorelli, MR; Torre, G | 1 |
Akimoto, T; Hamano, Y; Iwazu, Y; Kusano, E; Miki, T; Muto, S; Numata, A; Otani, N; Saito, O; Sugase, T; Takemoto, F; Toshima, M; Ueda, Y | 1 |
Antinori, S; Corbellino, M; Dodero, A; Foschi, A; Mazzocchi, A; Micheli, V; Milazzo, L; Montefusco, V; Zehender, G | 1 |
Block, TM; Clearfield, E; Cuconati, A; Goddard, C; Guo, H; Mills, C; Morrey, JD; Motter, NE; Xiao, T; Xu, X; Yu, W; Zhao, K | 1 |
Giles, M; Sasadeusz, J; Visvanathan, K | 1 |
Holodniy, M; Schirmer, P; Winters, M | 1 |
Branger, M; Collin, G; Fraqueiro, G; Gervais, A; Hamet, G; Lada, O; Marcellin, P; Martinot-Peignoux, M; Matheron, S; Moucari, R; Peytavin, G; Roquebert, B | 1 |
Dalekos, GN; Tillmann, HL; Zachou, K | 1 |
García-Alonso, FJ; Martín-Mateos, RM; Moreira Vicente, V | 1 |
Boyd, A; Delaugerre, C; Girard, PM; Lacombe, K; Lavocat, F; Maylin, S; Simon, F; Zoulim, F | 1 |
Fontana, RJ; Singal, AK | 1 |
Cotterell, AH; Fisher, RA; Kimmel, M; Luketic, VA; Posner, MP; Puri, P; Sanyal, AJ; Shiffman, ML; Sterling, RK; Stravitz, RT | 1 |
Bower, M; Kumar, N; Nelson, M | 1 |
Gervain, J; Horváth, G; Hunyady, B; Makara, M; Pár, A; Szalay, F; Telegdy, L; Tornai, I; Ujhelyi, E | 1 |
Ding, Y; Jia, Y; Liu, W; Lu, C; Song, Y; Sun, X; Wen, A; Yang, J | 1 |
Akriviadis, E; Antoniadis, N; Cholongitas, E; Goulis, I; Papanikolaou, V; Vasiliadis, T | 1 |
Kim, JH; Psevdos, G; Sharp, V | 1 |
Hall, AM | 1 |
Berg, T; Bock, FJ; Deterding, K; Feucht, HH; Hüppe, D; Möller, B; Trojan, J; van Bömmel, F; Wasmuth, HE; Wedemeyer, H | 1 |
Babiker, ZOE; Hogan, C; Ustianowski, A; Wilkins, E | 1 |
Arzumanyan, A; Bassit, L; Clayton, MM; Feitelson, MA; Kohler, JJ; Obikhod, A; Schinazi, RF; Sun, B | 1 |
Grabmeier-Pfistershammer, K; Kosi, L; Payer, BA; Peck-Radosavljevic, M; Reiberger, T; Rieger, A; Strassl, R | 1 |
Gatanaga, H; Gomibuchi, H; Hosokawa, S; Kikuchi, Y; Kinai, E; Oka, S | 1 |
Cholongitas, E; Papatheodoridis, GV | 1 |
Angeli, P; Cavallin, M; Fasolato, S; Gatta, A; Gola, E; Morando, F; Rosi, S | 1 |
Budeus, B; Cao, L; Chen, X; Hoffmann, D; Lu, M; Qin, B; Rayner, S; Wang, Y; Wu, C; Zhang, X | 1 |
Agnaf, MR; Coyle, PV; Feeney, SA; Gerlich, WH; McCaughey, C; McDougall, N; Watt, AP; Wend, UC | 1 |
Ingiliz, P; Ivanka, K; Krznaric, I; Martin, O; Obermeier, M; Patrick, I | 1 |
Candusso, M; Iorio, R; Liccardo, D; Riva, S; Torre, G; Tufano, M | 1 |
Berg, T; Schürmann, D; van Bömmel, F; Wünsche, T | 1 |
Dieterich, DT | 1 |
Fung, HB; Piacenti, FJ; Stone, EA | 1 |
Benhamou, Y; Thibault, V; Tubiana, R | 1 |
Berg, T; Hopf, U; Schernick, A; Van Bömmel, F | 1 |
Vere Hodge, A | 1 |
Buster, EH; Schalm, SW; van der Eijk, AA | 1 |
Benhamou, Y | 1 |
Benhamou, Y; Cahour, A; Katlama, C; Lada, O; Poynard, T; Thibault, V | 1 |
Bani-Sadr, F; Molina, JM; Palmer, P; Scieux, C | 1 |
Duncan, R; Lau, DT; Madariaga, JR; Montalbano, M; Muslu, H; Neff, GW; Nery, C; Nery, J; O'Brien, CB; Ruiz, P; Safdar, K; Schiff, ER; Shire, NJ; Tzakis, AG | 1 |
Däumer, M; Kaiser, R; Matz, B; Rockstroh, JK; Schewe, CK; Schildgen, O; Vogel, M; Weitner, L | 1 |
Cañas, C; Casais, LA; Casanova, A; Chahri, N; Figueras, J; Gornals, J; Lopez, C; Taltavull, TC; Verdura, B | 1 |
Berg, T; van Bömmel, F | 1 |
Buti, M; Esteban, R | 1 |
Bartholomeusz, A; Camino, N; Klausen, G; Kuiper, M; Locarnini, S; Lutz, T; Mauss, S; Núñez, M; Rodés, B; Sheldon, J; Soriano, V; Tacke, F | 1 |
de Man, RA; de Vries-Sluijs, TE; Hansen, BE; Osterhaus, AD; van der Eijk, AA; van der Ende, ME | 1 |
Benhamou, Y; Fleury, H; Katlama, C; Le Teuff, G; Pellegrin, I; Piketty, C; Rozenbaum, W; Trimoulet, P; Trylesinski, A; Urbinelli, R | 1 |
Schiff, ER; Schreibman, IR | 1 |
Gallant, JE; Pham, PA | 1 |
Lok, AS; Wong, SN | 1 |
Berg, T; Feucht, HH; Hüppe, D; Möller, B; Sarrazin, C; Spengler, U; van Bömmel, F; Wiedenmann, B; Zöllner, B | 1 |
Grant, RM; Levy, V | 1 |
Alloui, C; Bouhassoune, K; Calboreanu, A; Dény, P; Gordien, E; Legal, F; Podevin, P; Rico-Garcia, M; Salmon-Céron, D; Sogni, P | 1 |
Hester, J; Jain, MK; Lee, WM; Parekh, NK | 1 |
Attar, N; Comanor, L; Elkin, C; Jain, MK; Keiser, P; Kipnis, P; Lee, WM; Leung, K; Ocampo, A; White, C | 1 |
Lok, AS; Tan, J | 1 |
Rimland, D; Rouphael, NG; Talati, NJ | 1 |
Dore, GJ; Matthews, GV | 1 |
Cooper, DA; Dore, GJ; Matthews, GV | 1 |
Colombo, S; Del Poggio, P; Jamoletti, C; Oggionni, M; Puhalo, V; Zaccanelli, M | 1 |
Ayliffe, U; Dervisevic, S; Garcia-Diaz, A; Geretti, AM; Gilson, R; Johnson, M; Nebbia, G; Smith, C; Tedder, R | 1 |
Clayton, MM; Feitelson, MA; Schinazi, RF; Sun, B | 1 |
Janssen, HL; Reijnders, JG | 1 |
Degertekin, B; Husain, M; Lok, AS; Oberhelman, K; Tan, J; Wong, SN | 1 |
56 review(s) available for tenofovir and Hepatitis B
Article | Year |
---|---|
Tribute to John C. Martin at the Twentieth Anniversary of the Breakthrough of Tenofovir in the Treatment of HIV Infections.
Topics: Alanine; Anti-HIV Agents; Drug Therapy, Combination; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Hepatitis B; History, 20th Century; History, 21st Century; HIV; HIV Infections; Humans; Pre-Exposure Prophylaxis; Reverse Transcriptase Inhibitors; Tenofovir | 2021 |
Tenofovir-induced renal and bone toxicity: report of two cases and literature review.
Topics: Anti-HIV Agents; Female; Hepatitis B; HIV Infections; Humans; Kidney; Kidney Diseases; Middle Aged; Tenofovir | 2022 |
Comparative efficacy and safety of pharmacologic interventions to prevent mother-to-child transmission of hepatitis B virus: a systematic review and network meta-analysis.
Topics: Antiviral Agents; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Infant; Infectious Disease Transmission, Vertical; Network Meta-Analysis; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Viral Load | 2022 |
Tenofovir disoproxil fumarate therapy to prevent hepatitis B virus vertical transmission-A review of maternal and infant outcomes.
Topics: Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Infant; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Viral Load | 2022 |
Risks and benefits of oral HIV pre-exposure prophylaxis for people with chronic hepatitis B.
Topics: Antiviral Agents; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; Humans; Pre-Exposure Prophylaxis; Risk Assessment; Tenofovir | 2022 |
The Use of Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide for Preventing Vertical Transmission of Hepatitis B.
Topics: Adenine; Antiviral Agents; Female; Hepatitis B; Hepatitis B, Chronic; Humans; Infant; Infectious Disease Transmission, Vertical; Tenofovir | 2023 |
Fuzheng Huayu preparation (/) combined with tenofovir disoproxil fumarate on hepatitis B: a systematic review and Meta-analysis.
Topics: Albumins; Antiviral Agents; Collagen Type III; Hepatitis B; Humans; Liver Cirrhosis; Tenofovir; Treatment Outcome | 2023 |
Risk of dyslipidemia in chronic hepatitis B patients taking tenofovir alafenamide: a systematic review and meta-analysis.
Topics: Adenine; Alanine; Cholesterol; Cholesterol, LDL; Dyslipidemias; Hepatitis B; Hepatitis B, Chronic; Humans; Tenofovir; Triglycerides | 2023 |
Fanconi syndrome induced by the long-term use of tenofovir disoproxil fumarate: a case report and literature review.
Topics: Fanconi Syndrome; Female; Hepatitis B; Humans; Pain; Tenofovir; Tomography, X-Ray Computed | 2023 |
Renal and bone side effects of long-term use of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide fumarate in patients with Hepatitis B: a network meta-analysis.
Topics: Adenine; Alanine; Antiviral Agents; Bone and Bones; Creatinine; Fumarates; Hepatitis B; Hepatitis B, Chronic; Humans; Kidney; Network Meta-Analysis; Tenofovir; Treatment Outcome | 2023 |
Efficacy and safety of tenofovir disoproxil fumarate versus entecavir in the treatment of acute-on-chronic liver failure with hepatitis B: a systematic review and meta-analysis.
Topics: Acute-On-Chronic Liver Failure; Antiviral Agents; End Stage Liver Disease; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Prospective Studies; Retrospective Studies; Severity of Illness Index; Tenofovir; Treatment Outcome | 2023 |
[Research progress on the effect of tenofovir disoproxil fumarate on blood lipid profile].
Topics: Adenine; Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lipids; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome | 2023 |
Role of tenofovir disoproxil fumarate in prevention of perinatal transmission of hepatitis B virus from mother to child: a systematic review and meta-analysis.
Topics: Antiviral Agents; Child; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Mothers; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Tenofovir; Treatment Outcome; Viral Load | 2021 |
Hepatitis B-management of acute infection and active inflammation in pregnancy-a hepatologist's perspective.
Topics: Adult; Antiviral Agents; Child; DNA, Viral; Female; Gastroenterologists; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Infant; Infectious Disease Transmission, Vertical; Inflammation; Male; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Telbivudine; Tenofovir | 2020 |
Combination of Entecavir or Tenofovir with Pegylated Interferon-α for Long-Term Reduction in Hepatitis B Surface Antigen Levels: Simultaneous, Sequential, or Add-on Combination Therapy.
Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Genotype; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Organophosphonates; Randomized Controlled Trials as Topic; Reproducibility of Results; Tenofovir; Treatment Outcome; Viral Load | 2021 |
Antiviral prophylaxis against hepatitis B recurrence after liver transplantation: Current concepts.
Topics: Antiviral Agents; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Liver Transplantation; Recurrence; Tenofovir; Treatment Outcome | 2021 |
Efficacy and safety of tenofovir disoproxil fumarate in preventing vertical transmission of hepatitis B in pregnancies with high viral load.
Topics: Adult; Antiviral Agents; Female; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Odds Ratio; Outcome Assessment, Health Care; Pregnancy; Publication Bias; Tenofovir; Viral Load | 2017 |
Antiretroviral therapy for pregnant women living with HIV or hepatitis B: a systematic review and meta-analysis.
Topics: Adult; Anti-Retroviral Agents; Drug Combinations; Emtricitabine; Female; Hepatitis B; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Lopinavir; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Ritonavir; Tenofovir; Young Adult; Zidovudine | 2017 |
Role of tenofovir alafenamide (TAF) in the treatment and prophylaxis of HIV and HBV infections.
Topics: Adenine; Alanine; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; HIV Infections; Humans; Pre-Exposure Prophylaxis; Tenofovir; Treatment Outcome | 2018 |
Potential kidney toxicity from the antiviral drug tenofovir: new indications, new formulations, and a new prodrug.
Topics: Adenine; Alanine; Antiviral Agents; Bone Density; Drug Interactions; Glomerular Filtration Rate; Hepatitis B; HIV Infections; Humans; Kidney Diseases; Pre-Exposure Prophylaxis; Prodrugs; Tenofovir | 2018 |
Hepatitis B reactivation in patients receiving direct-acting antiviral therapy or interferon-based therapy for hepatitis C: A systematic review and meta-analysis.
Topics: Antibiotic Prophylaxis; Antiviral Agents; Coinfection; Disease Progression; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C; Humans; Incidence; Interferons; Recurrence; Tenofovir; Treatment Outcome; Virus Activation | 2018 |
Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV/HIV coinfection: a meta-analysis.
Topics: Alanine Transaminase; Antiviral Agents; Coinfection; Drug Therapy, Combination; Hepatitis B; Hepatitis B e Antigens; HIV Infections; Humans; Lamivudine; RNA, Viral; Tenofovir; Treatment Outcome | 2018 |
Okuda lecture: Challenges of hepatitis B in the era of antiviral therapy.
Topics: Antiviral Agents; Biomarkers; Carcinoma, Hepatocellular; Guanine; Hepatitis B; Hepatitis B e Antigens; Humans; Immune Tolerance; Liver Neoplasms; Nucleotides; Tenofovir; Withholding Treatment | 2019 |
Comparative effectiveness of anti-viral drugs with dual activity for treating hepatitis B and HIV co-infected patients: a network meta-analysis.
Topics: Adenine; Adult; Aged; Antiviral Agents; Coinfection; Emtricitabine; Female; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Network Meta-Analysis; Organophosphonates; Tenofovir; Treatment Outcome; Young Adult | 2018 |
Evidence for Use of Tenofovir in Pregnancy to Prevent Perinatal Transmission of Hepatitis B Infection.
Topics: Antiviral Agents; Female; Hepatitis B; Hepatitis B virus; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Viremia | 2019 |
Guides concerning tenofovir exposure via breastfeeding: A comparison of drug dosages by developmental stage.
Topics: Animals; Anti-HIV Agents; Antiviral Agents; Female; Hepatitis B; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Male; Milk, Human; Pregnancy; Pregnancy Complications, Infectious; Tenofovir | 2019 |
Suppression of HBV by tenofovir in HBV/HIV coinfected patients: a systematic review and meta-analysis.
Topics: Adenine; Anti-HIV Agents; Coinfection; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Organophosphonates; Tenofovir | 2013 |
Regression of fibrosis after HBV antiviral therapy. Is cirrhosis reversible?
Topics: Adenine; Administration, Oral; Antiviral Agents; Carcinoma, Hepatocellular; Fibrosis; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Nucleosides; Organophosphonates; Telbivudine; Tenofovir; Thymidine | 2014 |
Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection.
Topics: Adenine; Antiviral Agents; Coinfection; DNA, Viral; Drug Therapy, Combination; Guanine; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C; Hepatitis C, Chronic; HIV Infections; Humans; Organophosphonates; Ribavirin; RNA, Viral; Tenofovir; Virus Replication | 2014 |
Management of patients with overt or resolved hepatitis B virus infection undergoing rituximab therapy.
Topics: Adenine; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; Arthritis, Rheumatoid; Autoimmune Diseases; Carrier State; Disease Management; DNA, Viral; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Organophosphonates; Rituximab; Tenofovir; Virus Activation | 2014 |
Prevention of hepatitis B virus reinfection in liver transplant recipients.
Topics: Adenine; Antiviral Agents; Guanine; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Liver; Liver Cirrhosis; Liver Transplantation; Organophosphonates; Recurrence; Reverse Transcriptase Inhibitors; Tenofovir; Transplant Recipients; Virus Replication | 2014 |
Breastfeeding while taking lamivudine or tenofovir disoproxil fumarate: a review of the evidence.
Topics: Adenine; Anti-HIV Agents; Breast Feeding; Disease Transmission, Infectious; Female; Hepatitis B; Humans; Infant, Newborn; Lamivudine; Organophosphonates; Pregnancy; Tenofovir | 2015 |
Hepatitis B virus mutation may play a role in hepatocellular carcinoma recurrence: A systematic review and meta-regression analysis.
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Combined Modality Therapy; Databases, Bibliographic; Female; Guanine; Hepatitis B; Hepatitis B virus; Humans; Liver Neoplasms; Male; Middle Aged; Mutation; Neoplasm Recurrence, Local; Prognosis; Regression Analysis; Tenofovir | 2015 |
Tenofovir alafenamide (Vemlidy) for hepatitis B.
Topics: Adenine; Alanine; Animals; Antiviral Agents; Clinical Trials as Topic; Hepatitis B; Humans; Tenofovir | 2017 |
Antiviral therapies for managing viral hepatitis in lymphoma patients.
Topics: Antiviral Agents; Guanine; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis C; Humans; Lamivudine; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Rituximab; Tenofovir; Virus Activation | 2017 |
Hepatitis B and liver transplantation: 2008 update.
Topics: Adenine; Antiviral Agents; Drug Therapy, Combination; Guanine; Hepatitis B; Hepatitis B Vaccines; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Nucleosides; Organophosphonates; Pyrimidinones; Telbivudine; Tenofovir; Thymidine | 2009 |
[Hepatitis B in patients with HIV infection].
Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Comorbidity; Deoxycytidine; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; Guanine; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; HIV; HIV Infections; Humans; Interferon-alpha; Lamivudine; Nucleosides; Organophosphonates; Practice Guidelines as Topic; Pyrimidinones; Reverse Transcriptase Inhibitors; Telbivudine; Tenofovir; Thymidine; Virus Replication | 2008 |
Post-liver transplant hepatitis B prophylaxis: the role of oral nucleos(t)ide analogues.
Topics: Adenine; Administration, Oral; Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Graft Survival; Guanine; Hepatitis B; Humans; Immunoglobulins; Injections, Intramuscular; Lamivudine; Liver Transplantation; Nucleosides; Nucleotides; Organophosphonates; Secondary Prevention; Tenofovir; Treatment Outcome | 2009 |
Current therapeutic strategies for recurrent hepatitis B virus infection after liver transplantation.
Topics: Adenine; Antiviral Agents; Asia; Guanine; Hepatitis B; Hepatitis B virus; Humans; Interferons; Lamivudine; Liver Transplantation; Organophosphonates; Recurrence; Reverse Transcriptase Inhibitors; Tenofovir | 2010 |
Inflammatory bowel disease and hepatitis B and C in Western Balkans: a referral centre study and review of the literature.
Topics: Adenine; Adolescent; Adult; Aged; Antiviral Agents; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Female; Greece; Hepatitis B; Hepatitis C; Humans; Inflammatory Bowel Diseases; Interferon-alpha; Lamivudine; Male; Middle Aged; Organophosphonates; Prevalence; Retrospective Studies; Ribavirin; Tenofovir; Treatment Outcome | 2010 |
The impact of human immunodeficiency virus on viral hepatitis.
Topics: Adenine; Antiviral Agents; Deoxycytidine; Disease Progression; Drug Therapy, Combination; Emtricitabine; Guanine; Hepatitis B; Hepatitis C; Hepatitis Viruses; HIV Infections; Humans; Interferon-alpha; Lamivudine; Nucleosides; Organophosphonates; Pyrimidinones; Telbivudine; Tenofovir; Thymidine | 2011 |
The clinical potential of the acyclic (and cyclic) nucleoside phosphonates: the magic of the phosphonate bond.
Topics: Adenine; Antineoplastic Agents; Antiviral Agents; Cidofovir; Cytosine; Guanosine; Hepatitis B; HIV Infections; Humans; Organophosphonates; Prodrugs; Structure-Activity Relationship; Tenofovir | 2011 |
Antiviral therapy for hepatitis B infection during pregnancy and breastfeeding.
Topics: Adenine; Antiviral Agents; Breast Feeding; Female; Guanine; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Nucleosides; Organophosphonates; Placenta; Pregnancy; Pregnancy Complications, Infectious; Pyrimidinones; Telbivudine; Tenofovir; Thymidine | 2011 |
Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat?
Topics: Adenine; Antiviral Agents; Guanine; Hepatitis B; Humans; Interferons; Lamivudine; Liver Failure, Acute; Organophosphonates; Tenofovir | 2012 |
[Pharmacological treatment of acute hepatitis B].
Topics: Acute Disease; Adenine; Antiviral Agents; Guanine; Hepatitis B; Humans; Lamivudine; Nucleosides; Organophosphonates; Practice Guidelines as Topic; Pyrimidinones; Spain; Telbivudine; Tenofovir; Thymidine; Treatment Outcome | 2012 |
Meta-analysis: oral anti-viral agents in adults with decompensated hepatitis B virus cirrhosis.
Topics: Adenine; Administration, Oral; Adult; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Guanine; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Nucleosides; Organophosphonates; Pyrimidinones; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Telbivudine; Tenofovir; Thymidine; Time Factors; Treatment Outcome; Viral Load | 2012 |
Update on tenofovir toxicity in the kidney.
Topics: Adenine; Animals; Anti-HIV Agents; Antiviral Agents; Hepatitis B; HIV Infections; Humans; Kidney; Kidney Diseases; Organophosphonates; Risk Factors; Tenofovir | 2013 |
High genetic barrier nucleos(t)ide analogue(s) for prophylaxis from hepatitis B virus recurrence after liver transplantation: a systematic review.
Topics: Adenine; Antiviral Agents; DNA, Viral; Guanine; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Liver Failure; Liver Transplantation; Nucleotides; Organophosphonates; Recurrence; Tenofovir; Time Factors; Treatment Outcome | 2013 |
Tenofovir disoproxil fumarate: a nucleotide reverse transcriptase inhibitor for the treatment of HIV infection.
Topics: Adenine; Animals; Anti-HIV Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Resistance, Viral; Drug Synergism; Drug Therapy, Combination; Hepatitis B; HIV Infections; HIV-1; Humans; Organophosphonates; Organophosphorus Compounds; Reverse Transcriptase Inhibitors; Tenofovir | 2002 |
Doctor to patient transmission of hepatitis B virus: implications of HBV DNA levels and potential new solutions.
Topics: Adenine; Antiviral Agents; DNA, Viral; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Infectious Disease Transmission, Professional-to-Patient; Interferon-alpha; Lamivudine; Organophosphonates; Organophosphorus Compounds; Physicians; Risk Factors; Risk Management; Tenofovir; Viral Load | 2003 |
Drugs in development for hepatitis B.
Topics: Adenine; Antiviral Agents; Arabinofuranosyluracil; Deoxycytidine; Emtricitabine; Guanine; Hepatitis B; Humans; Interferon alpha-2; Interferon-alpha; Nucleosides; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; Tenofovir | 2005 |
Prevention and treatment of recurrent Hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analogues.
Topics: Adenine; Antiviral Agents; Drug Therapy, Combination; Guanine; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Nucleosides; Nucleotides; Organophosphonates; Recurrence; Tenofovir | 2006 |
Tenofovir disoproxil fumarate for the treatment of HIV infection.
Topics: Adenine; Animals; Drug Administration Schedule; Drug Interactions; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; HIV Infections; Humans; Organophosphonates; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Tenofovir | 2006 |
Tenofovir disoproxil fumarate: role in hepatitis B treatment.
Topics: Adenine; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Organophosphonates; Tenofovir; Treatment Outcome | 2006 |
Antiretroviral therapy for hepatitis B virus-HIV-coinfected patients: promises and pitfalls.
Topics: Adenine; Antiretroviral Therapy, Highly Active; Antiviral Agents; Deoxycytidine; Drug Combinations; Emtricitabine; Guanine; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Organophosphonates; Preventive Medicine; Tenofovir | 2006 |
Hepatitis B reverse seroconversion in HIV-positive patients: case series and review of the literature.
Topics: Adenine; Adult; Aged; Aged, 80 and over; Anti-HIV Agents; CD4 Lymphocyte Count; DNA, Viral; Hepatitis B; Hepatitis B Surface Antigens; HIV Seropositivity; Humans; Lamivudine; Middle Aged; Organophosphonates; Tenofovir | 2007 |
34 trial(s) available for tenofovir and Hepatitis B
Article | Year |
---|---|
Randomized Controlled Study of Tenofovir versus Lamivudine Followed by Tenofovir in Severe Exacerbation of Hepatitis B.
Topics: Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Tenofovir; Treatment Outcome | 2022 |
Inhibition of Viral Replication Reduces Transcriptionally Active Distinct Hepatitis B Virus Integrations With Implications on Host Gene Dysregulation.
Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; RNA; Tenofovir; Treatment Outcome; Viral Load; Viremia; Virus Integration; Virus Replication | 2022 |
Immunoglobulin-free strategy to prevent HBV mother-to-child transmission in Cambodia (TA-PROHM): a single-arm, multicentre, phase 4 trial.
Topics: Alanine Transaminase; Antiviral Agents; Cambodia; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Tenofovir; Viral Load | 2022 |
Characterization of Hepatitis B Virus in Tenofovir-Treated and Untreated Chronically Infected Mothers and Their Immunoprophylaxis Failure Infants.
Topics: Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Infant; Infectious Disease Transmission, Vertical; Mothers; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Viremia | 2023 |
A phase 2, open-label, randomized, multiple-dose study evaluating Inarigivir in treatment-naïve patients with chronic hepatitis B.
Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; RNA; Tenofovir; Treatment Outcome | 2023 |
Tenofovir versus entecavir on the prognosis of hepatitis B-related hepatocellular carcinoma after surgical resection: a randomised controlled trial.
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis B; Hepatitis B, Chronic; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Prognosis; Tenofovir; Treatment Outcome | 2023 |
Efficacy of Antiviral Prophylaxis up to 6 or 12 Months From Completion of Rituximab in Resolved Hepatitis B Patients: A Multicenter, Randomized Study.
Topics: Antiviral Agents; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Prospective Studies; Rituximab; Symptom Flare Up; Tenofovir | 2023 |
The effect of switch therapy to tenofovir versus entecavir maintenance on recurrence of hepatocellular carcinoma after surgery (SWITE): study protocol for a randomized controlled trial.
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Tenofovir; Treatment Outcome | 2023 |
Tenofovir Alafenamide for Drug-Resistant Hepatitis B: A Randomized Trial for Switching From Tenofovir Disoproxil Fumarate.
Topics: Alanine; Antiviral Agents; Hepatitis B; Hepatitis B, Chronic; Humans; Tenofovir; Treatment Outcome | 2022 |
Is laboratory screening prior to antiretroviral treatment useful in Johannesburg, South Africa? Baseline findings of a clinical trial.
Topics: Adult; Albuminuria; Anemia; Anti-HIV Agents; Antigens; CD4 Lymphocyte Count; Cities; Clinical Laboratory Techniques; Coinfection; Cost-Benefit Analysis; Creatinine; Female; Health Care Costs; Hemoglobins; Hepatitis B; HIV Infections; Humans; Kidney Diseases; Male; Mass Screening; Neutropenia; South Africa; Tenofovir; Transaminases | 2017 |
Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antiviral Agents; Female; Hepatitis B; Hepatitis B virus; Humans; Leukemia; Male; Middle Aged; Post-Exposure Prophylaxis; Rituximab; Serologic Tests; Tenofovir | 2017 |
Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial.
Topics: Administration, Oral; Adult; Anti-HIV Agents; Biological Availability; Coinfection; Double-Blind Method; Emtricitabine; Female; Hepatitis B; Hepatitis C; HIV Infections; HIV-1; Humans; Male; Quality of Life; Raltegravir Potassium; RNA, Viral; Tenofovir; Viral Load | 2017 |
Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.
Topics: Adolescent; Adult; Alanine Transaminase; Antiviral Agents; DNA, Viral; Double-Blind Method; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Viral Load; Young Adult | 2018 |
96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection.
Topics: Adenine; Adolescent; Adult; Aged; Aged, 80 and over; Alanine; Alanine Transaminase; Bone Density; DNA, Viral; Double-Blind Method; Drug Resistance, Viral; Female; Glomerular Filtration Rate; Hepatitis B; Hepatitis B e Antigens; Humans; Male; Middle Aged; Tenofovir; Young Adult | 2018 |
Tenofovir Disoproxil Fumarate Use during Pregnancy and Infant Bone Health: the Tenofovir in Pregnancy Pilot Study.
Topics: Adult; Anti-HIV Agents; Bone and Bones; Bone Density; China; Coinfection; Female; Hepatitis B; HIV Infections; Humans; Infant; Infant Health; Pilot Projects; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Young Adult | 2018 |
Maternal and Infant Bone Mineral Density 1 Year After Delivery in a Randomized, Controlled Trial of Maternal Tenofovir Disoproxil Fumarate to Prevent Mother-to-child Transmission of Hepatitis B Virus.
Topics: Adult; Antiviral Agents; Bone Density; Double-Blind Method; Female; Gestational Age; Hepatitis B; Hepatitis B virus; Humans; Infant; Infectious Disease Transmission, Vertical; Male; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Viral Load; Young Adult | 2019 |
Impact on L-carnitine Homeostasis of Short-term Treatment with the Pivalate Prodrug Tenofovir Dipivoxil.
Topics: Adenine; Adult; Antiviral Agents; Carnitine; Dose-Response Relationship, Drug; Female; Hepatitis B; Herpes Simplex; Homeostasis; Humans; Male; Organophosphonates; Prodrugs; Tenofovir | 2013 |
Use of tenofovir disoproxil fumarate in highly viremic, hepatitis B mono-infected pregnant women.
Topics: Adenine; Adolescent; Adult; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Odds Ratio; Organophosphonates; Pregnancy; Risk Factors; Tenofovir; Viremia; Young Adult | 2014 |
Tenofovir/entecavir monotherapy after hepatitis B immunoglobulin withdrawal is safe and effective in the prevention of hepatitis B in liver transplant recipients.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Drug Administration Schedule; Female; Follow-Up Studies; Guanine; Hepatitis B; Humans; Immunoglobulins; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Prospective Studies; Recurrence; Tenofovir; Treatment Outcome; Young Adult | 2015 |
Proportion and factors associated with Hepatitis B viremia in antiretroviral treatment naïve and experienced HIV co-infected Ghanaian patients.
Topics: Adolescent; Adult; Anti-HIV Agents; Antiviral Agents; Coinfection; Cross-Sectional Studies; Female; Ghana; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Tenofovir; Viral Load; Viremia; Young Adult | 2016 |
Brief Report: Efficacy and Safety of Switching to a Single-Tablet Regimen of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1/Hepatitis B-Coinfected Adults.
Topics: Adenine; Alanine; Anti-HIV Agents; Cobicistat; Coinfection; Drug Combinations; Drug Substitution; Emtricitabine; Female; Hepatitis B; HIV Infections; Humans; Male; Middle Aged; Quinolones; Tenofovir; Treatment Outcome | 2016 |
Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus
Topics: Adult; Alanine Transaminase; Antibiotic Prophylaxis; Antiviral Agents; Biomarkers; Double-Blind Method; Female; Gestational Age; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Humans; Immunoglobulins; Infant; Infectious Disease Transmission, Vertical; Mothers; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Thailand; Viral Load | 2016 |
Prospective interventional study of tenofovir in pregnancy to prevent vertical transmission of hepatitis B in highly viremic women.
Topics: Antiviral Agents; Biomarkers; Child, Preschool; DNA, Viral; Drug Administration Schedule; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Paris; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Prospective Studies; Tenofovir; Time Factors; Treatment Outcome; Viral Load; Viremia | 2017 |
Breakthrough in the prevention of mother-to-child hepatitis B transmission?
Topics: Adult; Antiviral Agents; Congenital Abnormalities; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Viral Load; Young Adult | 2017 |
Evidence of long-term suppression of hepatitis B virus DNA by tenofovir as rescue treatment in patients coinfected by HIV.
Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; DNA Mutational Analysis; DNA, Viral; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Mutation; Organophosphonates; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Tenofovir; Time Factors; Treatment Outcome; Virus Replication | 2008 |
A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand.
Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; DNA, Viral; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Prospective Studies; Tenofovir; Thailand; Treatment Outcome; Zidovudine | 2008 |
Comparison of the antiviral activity of adefovir and tenofovir on hepatitis B virus in HIV-HBV-coinfected patients.
Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Male; Middle Aged; Organophosphonates; Proportional Hazards Models; Tenofovir; Treatment Outcome; Viral Load | 2008 |
Viral dynamics of hepatitis B virus DNA in human immunodeficiency virus-1-hepatitis B virus coinfected individuals: similar effectiveness of lamivudine, tenofovir, or combination therapy.
Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Biopsy; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Immunosuppression Therapy; Lamivudine; Liver; Male; Middle Aged; Models, Biological; Organophosphonates; Prospective Studies; Tenofovir; Viral Load; Young Adult | 2009 |
Relative bioavailability study of a novel prodrug of tenofovir, tenofovir dipivoxil fumarate, in healthy male fasted volunteers.
Topics: Adenine; Administration, Oral; Adolescent; Adult; Area Under Curve; Biological Availability; Cross-Over Studies; Hepatitis B; Humans; Male; Middle Aged; Organophosphonates; Phosphorous Acids; Prodrugs; Reverse Transcriptase Inhibitors; Tenofovir; Therapeutic Equivalency; Young Adult | 2012 |
Ninety-six-week efficacy of combination therapy with lamivudine and tenofovir in patients coinfected with HIV-1 and wild-type hepatitis B virus.
Topics: Adenine; Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; Hepatitis B; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Tenofovir | 2004 |
Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir.
Topics: Adenine; Adult; Antiviral Agents; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Models, Molecular; Mutation; Organophosphonates; Reverse Transcriptase Inhibitors; Selection, Genetic; Tenofovir | 2005 |
Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV-coinfected patients: factors associated with response.
Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Tenofovir; Viral Load | 2007 |
Low-dose tenofovir is more potent than adefovir and is effective in controlling HBV viremia in chronic HBeAg-negative hepatitis B.
Topics: Adenine; Adult; Aged; Antiviral Agents; Dose-Response Relationship, Drug; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Male; Middle Aged; Organophosphonates; Tenofovir; Viremia | 2007 |
Tenofovir monotherapy is effective in hepatitis B patients with antiviral treatment failure to adefovir in the absence of adefovir-resistant mutations.
Topics: Adenine; Adult; Aged; Antiviral Agents; Deoxycytidine; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; Female; Hepatitis B; Hepatitis B, Chronic; Humans; Male; Middle Aged; Mutation; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Failure; Viral Load | 2008 |
248 other study(ies) available for tenofovir and Hepatitis B
Article | Year |
---|---|
Evaluation of hexadecyloxypropyl-9-R-[2-(Phosphonomethoxy)propyl]- adenine, CMX157, as a potential treatment for human immunodeficiency virus type 1 and hepatitis B virus infections.
Topics: Adenine; Animals; Anti-HIV Agents; Antiviral Agents; Cell Line; Female; Hepatitis B; Hepatitis B virus; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Magnetic Resonance Spectroscopy; Male; Organophosphonates; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Inhibitors; Tenofovir | 2007 |
Design, synthesis and biological evaluation of benzamide derivatives as novel NTCP inhibitors that induce apoptosis in HepG2 cells.
Topics: Antineoplastic Agents; Antiviral Agents; Apoptosis; Benzamides; Drug Design; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Humans; Molecular Docking Simulation; Organic Anion Transporters, Sodium-Dependent; Symporters; Virus Internalization | 2019 |
Combination Treatment with the Vimentin-Targeting Antibody hzVSF and Tenofovir Suppresses Woodchuck Hepatitis Virus Infection in Woodchucks.
Topics: Alanine; Animals; Antibodies, Monoclonal, Humanized; Antiviral Agents; Disease Models, Animal; Drug Therapy, Combination; Endocytosis; Hep G2 Cells; Hepatitis B; Hepatitis B Virus, Woodchuck; Host-Pathogen Interactions; Humans; Liver; Marmota; Tenofovir; Vimentin; Viral Load; Virus Internalization; Virus Replication | 2021 |
Body weight changes in treated hepatitis B patients switching to tenofovir alafenamide
Topics: Adenine; Alanine; Body Weight; Female; Hepatitis B; Hepatitis B, Chronic; Humans; Male; Middle Aged; Retrospective Studies; Tenofovir | 2022 |
Determinants of re-compensation in patients with hepatitis B virus-related decompensated cirrhosis starting antiviral therapy.
Topics: Antiviral Agents; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Tenofovir; Treatment Outcome | 2022 |
Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients.
Topics: Aged; Alanine; Antiviral Agents; Carcinoma, Hepatocellular; Guanine; Hepatitis B; Hepatitis B, Chronic; Humans; Liver Neoplasms; Male; Tenofovir; Treatment Outcome | 2021 |
Comparison of the efficacy and safety of tenofovir and telbivudine in interrupting mother-to-child transmission of hepatitis B virus.
Topics: Adult; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Telbivudine; Tenofovir; Viral Load | 2021 |
Evolution of Hepatitis B Virus (HBV) Serologic Markers Among Antiretroviral-Naive Young People Living With Human Immunodeficiency Virus Who Had Undergone Neonatal HBV Vaccination and Initiated Antiretroviral Therapy.
Topics: Adolescent; Adult; Anti-Retroviral Agents; DNA-Directed RNA Polymerases; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Herpesvirus 1, Cercopithecine; HIV; HIV Infections; Humans; Infant, Newborn; Retrospective Studies; Tenofovir; Vaccination; Young Adult | 2022 |
Tenofovir Alafenamide for Pregnant Chinese Women With Active Chronic Hepatitis B: A Multicenter Prospective Study.
Topics: Adenine; Adult; Antiviral Agents; China; Cleft Lip; Cleft Palate; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Infant, Newborn; Pregnancy; Pregnant Women; Prospective Studies; Tenofovir | 2022 |
Tenofovir alafenamide: An initial experience at Groote Schuur Hospital, Cape Town, South Africa.
Topics: Adult; Alanine; Antiviral Agents; Female; Follow-Up Studies; Glomerular Filtration Rate; Hepatitis B; Hepatitis B e Antigens; HIV Infections; Humans; Male; Middle Aged; Retrospective Studies; South Africa; Tenofovir; Treatment Outcome; Viral Load | 2022 |
Case of psoriasis with hepatitis B virus infection during tumor necrosis factor inhibitor treatment successfully treated with ixekizumab and tenofovir alafenamide fumarate.
Topics: Adenine; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Fumarates; Hepatitis B; Hepatitis B virus; Humans; Psoriasis; Tenofovir; Tumor Necrosis Factor Inhibitors | 2022 |
Downregulation of the long non-coding RNA MALAT1 in tenofovir-treated pregnant women with hepatitis B virus infection promotes immune recovery of natural killer cells via the has-miR-155-5p/HIF-1α axis.
Topics: Down-Regulation; Female; Hepatitis B; Hepatitis B virus; Humans; Infectious Disease Transmission, Vertical; Killer Cells, Natural; MicroRNAs; Pregnancy; Pregnant Women; RNA, Long Noncoding; Tenofovir | 2022 |
Editorial: does TAF have a better or worse safety profile than TDF, to treat hepatitis B?
Topics: Hepatitis B; Humans; Tenofovir | 2022 |
Editorial: does TAF have a better or worse safety profile than TDF, to treat hepatitis B? Authors' reply.
Topics: Hepatitis B; Humans; Tenofovir | 2022 |
First-line therapies for hepatitis B in the United States: A 3-year prospective and multicenter real-world study after approval of tenofovir alefenamide.
Topics: Alanine; Antiviral Agents; Hepatitis B; Hepatitis B, Chronic; Humans; Prospective Studies; Retrospective Studies; Tenofovir; United States | 2022 |
The role of tenofovir disoproxil fumarate for preventing vertical transmission of hepatitis B.
Topics: Antiviral Agents; DNA, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Infant; Infectious Disease Transmission, Vertical; Pregnancy; Tenofovir; Viral Load; Viremia | 2022 |
Plasma and breast milk pharmacokinetics of tenofovir alafenamide in mothers with chronic hepatitis B infection.
Topics: Adenine; Adult; Alanine; Anti-HIV Agents; Female; Hepatitis B; Hepatitis B, Chronic; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Milk, Human; Pregnancy; Tenofovir | 2022 |
Successful Treatment of Tenofovir Alafenamide-Induced Lactic Acidosis: A Case Report.
Topics: Acidosis, Lactic; Adenine; Antiviral Agents; Hepatitis B; Humans; Male; Middle Aged; Tenofovir | 2023 |
A Study on Pregenomic RNA and Factors Related to Hepatitis B Virus Infection Based on Real World.
Topics: DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; RNA, Viral; Tenofovir | 2022 |
A carrier-free metal-organic hybrid nanoassembly with combination anti-viral and hepato-protective activity for hepatitis B treatment.
Topics: Adenine; Animals; Antiviral Agents; DNA Replication; DNA, Viral; Hepatitis B; Hepatitis B virus; Inflammation; Mice; Organophosphates; Phosphates; Tenofovir; Virus Replication | 2022 |
Tenofovir Alafenamide use in pregnant women with chronic hepatitis B virus infection: more data needed.
Topics: Adenine; Alanine; Antiviral Agents; Female; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Pregnancy; Pregnant Women; Tenofovir | 2022 |
Plasma and breast milk pharmacokinetics of tenofovir alafenamide of mothers with chronic hepatitis B infection-Authors' reply.
Topics: Adenine; Alanine; Antiviral Agents; Female; Hepatitis B; Hepatitis B, Chronic; Humans; Milk, Human; Mothers; Tenofovir | 2022 |
Comparison of tenofovir disoproxil fumarate and telbivudine in preventing hepatitis B transmission in mothers with high viral load.
Topics: Alanine Transaminase; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Mothers; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Telbivudine; Tenofovir; Viral Load | 2023 |
Awareness and treatment of chronic hepatitis B in Malaysia-findings from a community-based screening campaign.
Topics: Adult; Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Malaysia; Tenofovir | 2022 |
Similar risk of kidney function decline between tenofovir alafenamide and besifovir dipivoxil maleate in chronic hepatitis B.
Topics: Adenine; Alanine; Antiviral Agents; Guanine; Hepatitis B; Hepatitis B, Chronic; Humans; Kidney; Longitudinal Studies; Maleates; Organophosphonates; Renal Insufficiency, Chronic; Retrospective Studies; Tenofovir; Treatment Outcome | 2022 |
Low prevalence of hepatitis B virus infection in HIV-uninfected pregnant women in Cape Town, South Africa: implications for oral pre-exposure prophylaxis roll out.
Topics: Adult; Cohort Studies; Cross-Sectional Studies; Emtricitabine; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; Humans; Infant; Pre-Exposure Prophylaxis; Pregnancy; Pregnant Women; Prevalence; South Africa; Tenofovir | 2022 |
The Elegance of the Acyclic Nucleoside Phosphonates (ANPs), Honorary Tribute to Antonín Holý, Who Passed Away on 16 July 2012, at the 10th Anniversary of His Death.
Topics: Anniversaries and Special Events; Anti-HIV Agents; Antiviral Agents; Cidofovir; Emtricitabine; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Nucleosides; Organophosphonates; Prodrugs; Tenofovir | 2022 |
[Prevention of Mother-To-Child Transmission of Hepatitis B Virus: Guidelines on Antiviral Prophylaxis in Pregnancy].
Topics: Adult; Antiviral Agents; Female; Germany; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Parturition; Pregnancy; Pregnancy Complications, Infectious; Tenofovir | 2023 |
Hepatitis B Virus (HBV) Replication During Tenofovir Therapy Is Frequent in Human Immunodeficiency Virus/HBV Coinfection.
Topics: Cohort Studies; Coinfection; DNA, Viral; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; HIV; HIV Infections; Humans; Tenofovir; Viral Load | 2023 |
Treating Hepatitis B Virus in Times of COVID-19: The Case for Clinical Pharmacogenomics Research in Tenofovir-Induced Kidney Toxicity.
Topics: Antiviral Agents; COVID-19; DNA, Viral; Ecosystem; Ghana; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Kidney; Pharmacogenetics; SARS-CoV-2; Tenofovir | 2022 |
Prospective cohort study of prevention of mother to child transmission of hepatitis B infection and 9 months follow-up of hepatitis B-exposed infants at Ile-Ife, Nigeria.
Topics: Adult; DNA, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunoglobulins; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nigeria; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Tenofovir | 2022 |
Long-Acting Treatments for Hepatitis B.
Topics: Antiviral Agents; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Tenofovir | 2022 |
Viral hepatitis in persons living with HIV in the post-COVID era.
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Coinfection; COVID-19; Drug Users; Hepatitis A; Hepatitis B; Hepatitis B, Chronic; Hepatitis C; Hepatitis C, Chronic; HIV Infections; Homosexuality, Male; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Sexual and Gender Minorities; Substance Abuse, Intravenous; Tenofovir | 2023 |
Converting from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Patients with Hepatitis B Following Liver Transplantation.
Topics: Adenine; Alanine; Antiviral Agents; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Transplantation; Retrospective Studies; Tenofovir | 2023 |
Cost-effectiveness of tenofovir prophylaxis during pregnancy for the elimination of mother-to-child transmission of the hepatitis B virus: real-world analysis from Thailand.
Topics: Antiviral Agents; Cost-Benefit Analysis; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Infant; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Tenofovir; Thailand; Viral Load | 2023 |
Entecavir versus tenofovir on the recurrence of hepatitis B-related HCC after liver transplantation: A multicenter observational study.
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Liver Transplantation; Tenofovir; Treatment Outcome | 2023 |
Hepatitis B care cascade among people with HIV/HBV coinfection in the North American AIDS Cohort Collaboration on Research and Design, 2012-2016.
Topics: Acquired Immunodeficiency Syndrome; Canada; Coinfection; Cross-Sectional Studies; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Male; Middle Aged; Tenofovir | 2023 |
Successful results of early nucleos(t)ide analogue treatment for liver transplantation candidates with severe acute hepatitis B infection.
Topics: Antiviral Agents; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Failure, Acute; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Tenofovir; Treatment Outcome | 2024 |
Antenatal hepatitis B virus sero-prevalence, risk factors, pregnancy outcomes and vertical transmission rate within 24 months after birth in a high HIV prevalence setting.
Topics: Child; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Mothers; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prevalence; Risk Factors; Seroepidemiologic Studies; Tenofovir | 2023 |
Long-term observation on hepatitis B surface antigen seroclearance in therapy experienced HIV/HBV co-infected Chinese.
Topics: Adult; Anti-HIV Agents; Antiviral Agents; Asian People; China; Coinfection; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Surface Antigens; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Retrospective Studies; Tenofovir; Time Factors; Young Adult | 2020 |
High Rates of Hepatitis B Virus (HBV) Functional Cure Among Human Immunodeficiency Virus-HBV Coinfected Patients on Antiretroviral Therapy in Zambia.
Topics: Adult; Anti-Retroviral Agents; CD4 Lymphocyte Count; Coinfection; Female; Hepatitis B; HIV Infections; Humans; Male; Prospective Studies; Tenofovir; Treatment Outcome; Viral Load; Zambia | 2020 |
Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan.
Topics: Adult; Anti-Retroviral Agents; Biomarkers; CD4 Lymphocyte Count; Coinfection; Female; Hemochromatosis; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Immunization Programs; Lamivudine; Male; Retrospective Studies; Seroepidemiologic Studies; Syphilis; Taiwan; Tenofovir; Young Adult | 2021 |
Rapid quantification of tenofovir in umbilical cord plasma and amniotic fluid in hepatitis B mono-infected pregnant women during labor by ultra-performance liquid chromatography/tandem mass spectrometry.
Topics: Amniotic Fluid; Animals; Antiviral Agents; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Fetal Blood; Hepatitis B; Humans; Limit of Detection; Pregnancy; Pregnancy Complications, Infectious; Tandem Mass Spectrometry; Tenofovir; Umbilical Cord | 2020 |
Clinical efficacy and safety in telbivudine- or tenofovir-treated hepatitis B e antigen-positive pregnant women.
Topics: Adult; Antiviral Agents; Female; Hepatitis B; Hepatitis B e Antigens; Humans; Infectious Disease Transmission, Vertical; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Telbivudine; Tenofovir; Treatment Outcome | 2020 |
Tenofovir prophylaxis for preventing mother-to-child hepatitis B virus transmission in China: A cost-effectiveness analysis.
Topics: Antiviral Agents; China; Cohort Studies; Cost-Benefit Analysis; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Immunization, Passive; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Quality-Adjusted Life Years; Tenofovir; Viral Load | 2020 |
HBV flare associated with immunosuppressive treatments: it is still dangerous in the third-generation antivirals era.
Topics: Alanine Transaminase; Antiviral Agents; Female; Guanine; Hepatitis B; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Symptom Flare Up; Tenofovir | 2020 |
Comparative efficacy of the front-line anti-HBV drugs in nucleos(t)ide analogue-naive chronic hepatitis B: A protocol for systematic review and network meta-analysis.
Topics: Antiviral Agents; Guanine; Hepatitis B; Hepatitis B virus; Humans; Meta-Analysis as Topic; Patient Selection; Randomized Controlled Trials as Topic; Systematic Reviews as Topic; Tenofovir | 2020 |
A pharmacokinetic study to guide dosing of tenofovir disoproxil fumarate during different modalities of renal replacement therapy.
Topics: Antiviral Agents; Drug Administration Schedule; Hemofiltration; Hepatitis B; Hepatitis B virus; Humans; Kidney Failure, Chronic; Middle Aged; Prospective Studies; Renal Insufficiency; Renal Replacement Therapy; Tenofovir | 2020 |
Impact of Lamivudine-Based Antiretroviral Treatment on Hepatitis B Viremia in HIV-Coinfected South Africans.
Topics: Adult; Anti-HIV Agents; Antiviral Agents; Coinfection; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Prospective Studies; Tenofovir; Viral Load; Viremia; Young Adult | 2020 |
The Risk of Acute Kidney Injury in Hepatitis B Virus-Related Acute on Chronic Liver Failure with Tenofovir Treatment.
Topics: Acute Kidney Injury; Acute-On-Chronic Liver Failure; Adult; Antiviral Agents; Female; Guanine; Hepatitis B; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Tenofovir; Treatment Outcome | 2020 |
Occult Hepatitis B Virus Infection in Immunized Infants Born to Untreated and Tenofovir-Treated Highly Viremic Mothers.
Topics: DNA, Viral; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Infant; Infectious Disease Transmission, Vertical; Mothers; Pregnancy; Tenofovir | 2021 |
Assessing the association between platelets and immune recovery in HIV/HBV co-infected patients: A long-term cohort in Asia.
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Blood Platelets; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Cohort Studies; Cyclopropanes; Female; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Immune Reconstitution; Lamivudine; Longitudinal Studies; Male; Platelet Count; Retrospective Studies; Tenofovir | 2020 |
Tenofovir for prevention of mother to child transmission of hepatitis B in migrant women in a resource-limited setting on the Thailand-Myanmar border: a commentary on challenges of implementation.
Topics: Adult; Antiviral Agents; Child; Female; Health Resources; Health Services Accessibility; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Immunoglobulins; Infectious Disease Transmission, Vertical; Male; Myanmar; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Rural Population; Tenofovir; Thailand; Transients and Migrants; Vaccination | 2020 |
Brief Report: Switching From TDF to TAF in HIV/HBV-Coinfected Individuals With Renal Dysfunction-A Prospective Cohort Study.
Topics: Adenine; Aged; Alanine; Anti-HIV Agents; Female; Glomerular Filtration Rate; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Interrupted Time Series Analysis; Kidney Diseases; Kidney Function Tests; Liver; Male; Middle Aged; Prospective Studies; Tenofovir; Viral Load | 2020 |
Prevention of mother-to-child transmission of hepatitis B virus: protocol for a one-arm, open-label intervention study to estimate the optimal timing of tenofovir in pregnancy.
Topics: Antiviral Agents; Child; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Myanmar; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Thailand; Viral Load | 2020 |
Effect of Pregnancy and Concomitant Antiretrovirals on the Pharmacokinetics of Tenofovir in Women With HIV Receiving Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Versus Women With HBV Receiving Tenofovir Disoproxil Fumarate Monotherapy.
Topics: Adult; Anti-HIV Agents; Area Under Curve; Drug Interactions; Female; Hepatitis B; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Retrospective Studies; Reverse Transcriptase Inhibitors; Tenofovir; Young Adult | 2021 |
Complex genetic encoding of the hepatitis B virus on-drug persistence.
Topics: Antiviral Agents; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Tenofovir | 2020 |
Tenofovir-disoproxil-fumarate modulates lipid metabolism via hepatic CD36/PPAR-alpha activation in hepatitis B virus infection.
Topics: Aged; Antiviral Agents; Female; Hepatitis B; Hepatitis B virus; Humans; Lipid Metabolism; Male; Middle Aged; PPAR alpha; Retrospective Studies; Tenofovir | 2021 |
Global Occurrence of Clinically Relevant Hepatitis B Virus Variants as Found by Analysis of Publicly Available Sequencing Data.
Topics: Access to Information; Antiviral Agents; Computer Simulation; Databases, Nucleic Acid; Genetic Variation; Genotype; Geography; Global Health; Hepatitis B; Hepatitis B virus; Humans; Sequence Analysis, DNA; Tenofovir | 2020 |
Optimization of the algorithm diagnosis chronic hepatitis B markers in patients with newly diagnosed HIV infection.
Topics: Algorithms; DNA, Viral; Genotype; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; Humans; Mutation; Tenofovir | 2020 |
Efficacy of Nucleotide/Nucleoside Analogues and Hepatitis B Immunoglobulin Therapy in Blocking Mother-to-Child Transmission of Hepatitis B in an Eastern Chinese Group.
Topics: Antiviral Agents; Case-Control Studies; China; DNA, Viral; Drug Administration Schedule; Female; Gestational Age; Hepatitis B; Hepatitis B Antigens; Hepatitis B virus; Humans; Immunoglobulins; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Telbivudine; Tenofovir; Treatment Outcome | 2020 |
Tenofovir Alafenamide to Prevent Perinatal Hepatitis B Transmission: A Multicenter, Prospective, Observational Study.
Topics: Alanine; Antiviral Agents; Female; Hepatitis B; Hepatitis B, Chronic; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Tenofovir; Viral Load | 2021 |
A Tenofovir-Loaded Glycyrrhetinic Acid-Modified Cationic Liposome for Targeted Therapy of Hepatitis B Virus.
Topics: Animals; Antiviral Agents; DNA, Viral; Glycyrrhetinic Acid; Hepatitis B; Hepatitis B virus; Liposomes; Tenofovir | 2020 |
Debate settled for elevated alanine aminotransferase in hepatitis B?
Topics: Alanine Transaminase; Double-Blind Method; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Tenofovir | 2021 |
Tenofovir disoproxil fumarate in pregnancy for prevention of mother to child transmission of hepatitis B in a rural setting on the Thailand-Myanmar border: a cost-effectiveness analysis.
Topics: Adult; Antiviral Agents; Cost-Benefit Analysis; Female; Hepatitis B; Humans; Infectious Disease Transmission, Vertical; Myanmar; Pregnancy; Pregnancy Complications, Infectious; Reproducibility of Results; Rural Population; Tenofovir; Thailand; Viral Load; Young Adult | 2021 |
Progress towards elimination of mother-to-child transmission of hepatitis B virus infection in China: a modelling analysis.
Topics: Adult; Antiviral Agents; China; Disease Eradication; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Humans; Immunoglobulins; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Tenofovir | 2021 |
Prevention of HBV Recurrence After Liver Transplant: Long-Term Results.
Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Drug Administration Schedule; Female; Guanine; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Immunoglobulins; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies; Tenofovir | 2021 |
A novel piperazine derivative that targets hepatitis B surface antigen effectively inhibits tenofovir resistant hepatitis B virus.
Topics: Antiviral Agents; Binding Sites; Catalytic Domain; DNA, Viral; Dose-Response Relationship, Drug; Drug Resistance, Viral; Genome, Viral; Genomics; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Models, Molecular; Piperazines; Protein Binding; Structure-Activity Relationship; Tenofovir; Virus Replication | 2021 |
Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort study.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Cohort Studies; Elasticity Imaging Techniques; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Kidney; Liver; Longitudinal Studies; Male; Middle Aged; Retrospective Studies; Tenofovir; Treatment Outcome; United Kingdom; Viral Load; Young Adult | 2021 |
Hepatitis B reactivation after tenofovir withdrawal in an HIV-infected patient with history of cured hepatitis B virus infection and poor immunological status.
Topics: Antiviral Agents; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; Humans; Tenofovir | 2021 |
Predominance of Hepatitis B Virus Genotype A Among Treated HIV Infected Patients Experiencing High Hepatitis B Virus Drug Resistance in Nairobi, Kenya.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Child, Preschool; Cross-Sectional Studies; DNA, Viral; Drug Resistance, Viral; Emtricitabine; Female; Genes, pol; Genotype; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Kenya; Lamivudine; Male; Middle Aged; Tenofovir; Viral Load; Young Adult | 2017 |
Tenofovir alafenamide for hepatitis B: evolution or revolution?
Topics: Anti-HIV Agents; Antiviral Agents; Hepatitis B; Hepatitis B, Chronic; HIV Infections; Humans; Tenofovir | 2016 |
Acute hepatitis B virus infection with delayed appearance of hepatitis B core antibody in an immunocompromised patient: a case report.
Topics: Antiviral Agents; Contact Tracing; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Immunocompromised Host; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Middle Aged; Rituximab; Tenofovir; Treatment Outcome | 2017 |
Is tenofovir the answer to further preventing mother-to-child transmission of hepatitis B?
Topics: Antiviral Agents; Child; Female; Hepatitis B; Hepatitis B, Chronic; Humans; Mothers; Tenofovir | 2016 |
Hepatitis B testing and treatment in HIV patients in The Gambia-Compliance with international guidelines and clinical outcomes.
Topics: Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; Coinfection; Cross-Sectional Studies; Female; Gambia; Hepatitis B; HIV Infections; Humans; Lamivudine; Male; Mass Screening; Middle Aged; Practice Guidelines as Topic; Tenofovir; Treatment Outcome; Young Adult | 2017 |
Fatal lactic acidosis in hepatitis B virus-associated decompensated cirrhosis treated with tenofovir: A case report.
Topics: Acidosis, Lactic; Antiviral Agents; Fatal Outcome; Hepatitis B; Humans; Liver Cirrhosis; Male; Middle Aged; Renal Dialysis; Tenofovir | 2017 |
Hepatitis B Reactivation in a Patient Receiving Chemotherapy for Breast Cancer: A Case Report.
Topics: Antineoplastic Agents; Antiviral Agents; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Hepatitis B; Hepatitis B virus; Humans; Immunosuppressive Agents; Liver Failure; Middle Aged; Paclitaxel; Tenofovir; Virus Activation | 2017 |
Physician testing for HIV in patients treated with tenofovir disoproxil fumarate and lamivudine monotherapy for hepatitis B virus.
Topics: AIDS Serodiagnosis; Attitude to Health; Cross-Sectional Studies; Hepatitis B; HIV Infections; Humans; Physician-Patient Relations; Practice Patterns, Physicians'; Reverse Transcriptase Inhibitors; Tenofovir | 2018 |
Letter: role of tenofovir to prevent mother-to-child transmission of hepatitis B virus-authors' reply.
Topics: Child; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Tenofovir | 2017 |
Letter: role of tenofovir to prevent mother-to-child transmission of hepatitis B virus.
Topics: Child; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy Complications, Infectious; Tenofovir | 2017 |
Rare clinically significant hepatic events and hepatitis B reactivation occur more frequently following rather than during direct-acting antiviral therapy for chronic hepatitis C: Data from a national US cohort.
Topics: Aged; Alanine Transaminase; Antiviral Agents; Cohort Studies; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Hepatitis C; Hepatitis C, Chronic; Humans; Liver; Male; Middle Aged; Telbivudine; Tenofovir; United States; Veterans; Virus Activation | 2018 |
Development of a digital droplet PCR assay to measure HBV DNA in patients receiving long-term TDF treatment.
Topics: Antiviral Agents; Clinical Trials, Phase III as Topic; DNA, Viral; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Limit of Detection; Polymerase Chain Reaction; Sensitivity and Specificity; Seroconversion; Tenofovir; Viral Load; Virus Replication | 2017 |
Resolution of acute hepatitis B-associated aplastic anaemia with antiviral therapy.
Topics: Adult; Anemia, Aplastic; Antiviral Agents; Female; Hepatitis B; Humans; Tenofovir; Treatment Outcome | 2017 |
Cerebellar ataxia and neuropathy as presenting features of hepatitis-B related cirrhosis and portal hypertension.
Topics: Antiviral Agents; Brain; Cerebellar Ataxia; Hepatitis B; Hepatolenticular Degeneration; Humans; Liver Cirrhosis; Magnetic Resonance Imaging; Male; Middle Aged; Tenofovir | 2017 |
Third-trimester tenofovir to prevent mother-to-child hepatitis B virus transmission.
Topics: Female; Hepatitis B; Hepatitis B virus; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Tenofovir | 2017 |
Antiviral therapy for hepatitis B virus during second pregnancies.
Topics: Adult; Antiviral Agents; Female; Gravidity; Hepatitis B; Hepatitis B virus; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Tenofovir | 2018 |
Call to Action: Prevention of Mother-to-Child Transmission of Hepatitis B in Africa.
Topics: Africa South of the Sahara; Antiviral Agents; Child; Female; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; HIV Infections; Humans; Immunization Programs; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Viral Load | 2018 |
Utilization of hepatitis B core antibody positive grafts in living donor liver transplantation.
Topics: Adolescent; Adult; Antiviral Agents; Female; Guanine; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Living Donors; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Risk; Tenofovir; Transplants; Virus Activation; Young Adult | 2018 |
Implementing preexposure prophylaxis among key populations: an opportunity for patient-centered services and management of hepatitis B.
Topics: Antiviral Agents; Cote d'Ivoire; Disease Transmission, Infectious; Female; Hepatitis B; HIV Infections; Humans; Male; Pre-Exposure Prophylaxis; Sex Workers; Tenofovir | 2018 |
Viral hepatitis: Maternal tenofovir use does not improve prevention of perinatal HBV transmission.
Topics: Female; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Tenofovir | 2018 |
Precore G1896A mutation is associated with reduced rates of HBsAg seroclearance in treated HIV hepatitis B virus co-infected patients from Western Africa.
Topics: Adult; Africa, Western; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antiviral Agents; DNA, Viral; Female; Genotype; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Mutation; Promoter Regions, Genetic; Prospective Studies; Tenofovir | 2018 |
Renal health after long-term exposure to tenofovir disoproxil fumarate (TDF) in HIV/HBV positive adults in Ghana.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Coinfection; Female; Ghana; Glomerular Filtration Rate; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Hypertension; Kidney; Kidney Diseases; Male; Middle Aged; Proteinuria; Tenofovir; Time Factors | 2018 |
Entecavir or tenofovir monotherapy prevents HBV recurrence in liver transplant recipients: A 5-year follow-up study after hepatitis B immunoglobulin withdrawal.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Drug Therapy, Combination; Female; Follow-Up Studies; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immunoglobulins; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Retrospective Studies; Tenofovir; Young Adult | 2018 |
HBV and HIV viral load but not microbial translocation or immune activation are associated with liver fibrosis among patients in South Africa.
Topics: Adult; Antiretroviral Therapy, Highly Active; Biomarkers; CD4-Positive T-Lymphocytes; Coinfection; Elasticity Imaging Techniques; Female; Hepatitis B; HIV Infections; Humans; Lipopolysaccharide Receptors; Liver Cirrhosis; Male; Middle Aged; South Africa; Tenofovir; Viral Load | 2018 |
Considerations of antiviral treatment to interrupt mother-to-child transmission of hepatitis B virus in China.
Topics: Adolescent; Adult; Antiviral Agents; China; Cost-Benefit Analysis; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Tenofovir; Viral Load; Young Adult | 2018 |
Successful Management of De Novo Acute Hepatitis B Virus Infection With Entecavir in a Living-Donor Liver Transplant Patient.
Topics: Adult; Antiviral Agents; Drug Substitution; Guanine; Hepatitis B; Hepatitis B virus; Humans; Immunocompromised Host; Immunosuppressive Agents; Liver Transplantation; Living Donors; Male; Tenofovir; Time Factors; Treatment Outcome | 2018 |
Tenofovir to Prevent Perinatal Transmission of Hepatitis B.
Topics: Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Tenofovir | 2018 |
Tenofovir to Prevent Perinatal Transmission of Hepatitis B.
Topics: Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Tenofovir | 2018 |
Tenofovir to Prevent Perinatal Transmission of Hepatitis B.
Topics: Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Tenofovir | 2018 |
Tenofovir to Prevent Perinatal Transmission of Hepatitis B.
Topics: Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Tenofovir | 2018 |
Changes in Liver Tissue Trace Element Concentrations During Hepatitis B Viral Infection Treatment.
Topics: Adult; Antiviral Agents; Biopsy; Female; Fibrosis; Guanine; Hepatitis B; Humans; Lamivudine; Liver; Liver Function Tests; Male; Middle Aged; Telbivudine; Tenofovir; Trace Elements; Young Adult | 2019 |
Tenofovir alafenamide associated fatal lactic acidosis in an autologous hematopoietic stem cell transplant recipient.
Topics: Acidosis, Lactic; Adenine; Aged; Alanine; Antiviral Agents; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis C; HIV Infections; Humans; Male; Multiple Myeloma; Tenofovir; Transplantation, Autologous | 2018 |
Risk of renal events during tenofovir disoproxil fumarate and entecavir antiviral prophylaxis in HBsAg-positive cancer patients undergoing chemotherapy.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Antiviral Agents; Chemoprevention; Drug-Related Side Effects and Adverse Reactions; Female; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Humans; Incidence; Male; Middle Aged; Neoplasms; Retrospective Studies; Risk Assessment; Tenofovir | 2018 |
Screening for hepatitis D and PEG-Interferon over Tenofovir enhance general hepatitis control efforts in Brazil.
Topics: Antiviral Agents; Brazil; Coinfection; Disease Transmission, Infectious; Female; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis D; Hepatitis Delta Virus; Humans; Interferons; Male; Models, Theoretical; Tenofovir; Viral Load | 2018 |
High Prevalence of HBV Lamivudine-Resistant Mutations in HBV/HIV Co-Infected Patients on Antiretroviral Therapy in the Area with the Highest Prevalence of HIV/HBV Co-Infection in China.
Topics: Adult; Anti-HIV Agents; China; Coinfection; DNA-Directed DNA Polymerase; Drug Resistance, Multiple, Viral; Female; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Lamivudine; Male; Multivariate Analysis; Mutation; Prevalence; Tenofovir; Viral Load | 2018 |
Timely Administration of Birth Dose Hepatitis B Virus Vaccine May Break the Chain of Perinatal Transmission.
Topics: Female; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Tenofovir | 2019 |
Letter: chronic kidney disease risk in patients with chronic hepatitis B-authors' reply.
Topics: Guanine; Hepatitis B; Hepatitis B, Chronic; Humans; Renal Insufficiency, Chronic; Tenofovir | 2018 |
Real-world study of tenofovir disoproxil fumarate to prevent hepatitis B transmission in mothers with high viral load.
Topics: Adult; Antiviral Agents; Breast Feeding; Female; Follow-Up Studies; Hepatitis B; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Postpartum Period; Prospective Studies; Tenofovir; Viral Load | 2019 |
Vertically acquired occult hepatitis B virus infection may become overt after several years.
Topics: Adult; Antiviral Agents; Child; Child, Preschool; DNA, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Immunoglobulins; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Prospective Studies; Sweden; Tenofovir; Young Adult | 2019 |
Clinical outcomes in patients with hepatitis D, cirrhosis and persistent hepatitis B virus replication, and receiving long-term tenofovir or entecavir.
Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Female; Follow-Up Studies; Guanine; Hepatitis B; Hepatitis B virus; Hepatitis D, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Prospective Studies; Tenofovir; Treatment Outcome | 2019 |
Letter: put on your thinking cap - tenofovir disoproxil fumarate for the prevention of vertical transmission of hepatitis B virus.
Topics: Female; Hepatitis B; Hepatitis B virus; Humans; Mothers; Tenofovir; Thinking; Viral Load | 2019 |
Letter: put on your thinking cap - tenofovir disoproxil fumarate for the prevention of vertical transmission of hepatitis B virus. Author's reply.
Topics: Female; Hepatitis B; Hepatitis B virus; Humans; Mothers; Tenofovir; Thinking; Viral Load | 2019 |
Reactivation of Hepatitis B Virus Infection With Reverse Seroconversion Following Umbilical Cord Allogeneic Hematopoietic Cell Transplantation in a Hepatitis-B-Immune Patient: A Case Report.
Topics: Aged; Antiviral Agents; Cord Blood Stem Cell Transplantation; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Male; Seroconversion; Tenofovir; Virus Activation | 2019 |
Effectiveness of tenofovir or telbivudine in preventing HBV vertical transmission for pregnancy.
Topics: Adolescent; Adult; Antiviral Agents; Case-Control Studies; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Retrospective Studies; Telbivudine; Tenofovir; Viral Load; Young Adult | 2019 |
Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients on tenofovir therapy: Relevance for screening strategies.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Carcinoma, Hepatocellular; Coinfection; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; HIV; Humans; Incidence; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Tenofovir | 2019 |
[Hepatitis B and renal failure: prevalence and associated factors in National University Hospital Center of Cotonou].
Topics: Adolescent; Adult; Age Factors; Aged; Antiviral Agents; Benin; Cross-Sectional Studies; Female; Glomerular Filtration Rate; Hepatitis B; Hepatitis B Surface Antigens; Hospitals, University; Humans; Hypertension; Male; Middle Aged; Prevalence; Renal Insufficiency; Risk Factors; Tenofovir; Young Adult | 2018 |
Successful treatment of HBV, HCV, & HEV, with 12-week long use of tenofovir, sofosbuvir, daclatasvir, and ribavirin: A case report.
Topics: Aged; Antiviral Agents; Asthma; Carbamates; Coinfection; Diabetes Complications; Drug Administration Schedule; Drug Therapy, Combination; Hepatitis B; Hepatitis C, Chronic; Hepatitis E; Humans; Imidazoles; Male; Pyrrolidines; Ribavirin; Sofosbuvir; Tenofovir; Treatment Outcome; Valine; Viral Load | 2020 |
Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa.
Topics: Adult; Antiviral Agents; Child; Cost-Benefit Analysis; Developing Countries; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infant; Infectious Disease Transmission, Vertical; Mass Screening; Models, Biological; Pregnancy; Pregnancy Complications, Infectious; South Africa; Tenofovir; Vaccination; Young Adult | 2019 |
Frequency of Hepatitis B Virus Resistance Mutations in Women Using Tenofovir Gel as Pre-Exposure Prophylaxis.
Topics: Administration, Intravaginal; Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Mutation; Pre-Exposure Prophylaxis; South Africa; Tenofovir; Young Adult | 2019 |
Fanconi syndrome due to tenofovir disoproxil fumarate (TDF) after liver transplantation.
Topics: Antiviral Agents; Fanconi Syndrome; Hepatitis B; Humans; Liver Transplantation; Male; Middle Aged; Tenofovir; Transplant Recipients | 2019 |
Brief Report: Relationship Between ABCC4 SNPs and Hepatitis B Virus Suppression During Tenofovir-Containing Antiretroviral Therapy in Patients With HIV/HBV Coinfection.
Topics: Adult; Anti-HIV Agents; Coinfection; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Logistic Models; Male; Middle Aged; Multidrug Resistance-Associated Proteins; Polymorphism, Single Nucleotide; Tenofovir | 2019 |
Letter: tenofovir disoproxil fumarate is safe for prevention of mother-to-child transmission of hepatitis B virus.
Topics: Child; Female; Hepatitis B; Hepatitis B virus; Humans; Infectious Disease Transmission, Vertical; Mothers; Tenofovir; Viral Load | 2019 |
Letter: tenofovir disoproxil fumarate is safe for prevention of mother-to-child transmission of hepatitis B virus. Authors' reply.
Topics: Child; Female; Hepatitis B; Hepatitis B virus; Humans; Infectious Disease Transmission, Vertical; Mothers; Tenofovir; Viral Load | 2019 |
Prophylactic effect of antiretroviral therapy on hepatitis B virus infection.
Topics: Adenine; Adult; Alanine Transaminase; Anti-Retroviral Agents; Antibiotic Prophylaxis; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; HIV Infections; Humans; Kaplan-Meier Estimate; Lamivudine; Male; Organophosphonates; Retrospective Studies; Tenofovir | 2013 |
Prevention of de novo hepatitis B with adefovir plus vaccination in recipients of liver transplants from core antibody-positive donors.
Topics: Adenine; Adult; Aged; Antiviral Agents; Biomarkers; Deoxycytidine; DNA, Viral; Drug Substitution; Emtricitabine; Guanine; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Liver Transplantation; Middle Aged; Organophosphonates; Tenofovir; Time Factors; Tissue Donors; Treatment Outcome | 2013 |
Prevention of de novo hepatitis B in recipients of core antibody-positive livers with lamivudine and other nucleos(t)ides: a 12-year experience.
Topics: Adenine; Adult; Aged; Analysis of Variance; Antiviral Agents; Biomarkers; Chi-Square Distribution; DNA, Viral; Donor Selection; Female; Guanine; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Logistic Models; Male; Middle Aged; Organophosphonates; Retrospective Studies; Risk Factors; Tenofovir; Time Factors; Tissue Donors; Treatment Outcome; Viral Load | 2013 |
Tenofovir treatment of the severe acute hepatitis B.
Topics: Acute Disease; Adenine; Antiviral Agents; Hepatitis B; Humans; Male; Middle Aged; Organophosphonates; Severity of Illness Index; Tenofovir | 2013 |
Access to treatment for HBV infection and its consistency with 2008 European guidelines in a multicentre cross-sectional study of HIV/HBV co-infected patients in Italy.
Topics: Adenine; Adult; Anti-Retroviral Agents; Coinfection; Cross-Sectional Studies; Deoxycytidine; Emtricitabine; Europe; Female; Guideline Adherence; Health Services Accessibility; Hepatitis B; HIV Infections; Humans; Infectious Disease Medicine; Italy; Lamivudine; Male; Multivariate Analysis; Organophosphonates; Practice Guidelines as Topic; Regression Analysis; Tenofovir; Treatment Outcome | 2013 |
Tenofovir-emtricitabine therapy for the prevention of hepatitis B recurrence in four patients after liver transplantation.
Topics: Adenine; Adult; Antiviral Agents; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; Female; Hepatitis B; Humans; Liver Transplantation; Male; Middle Aged; Organophosphonates; Secondary Prevention; Tenofovir | 2013 |
Living related liver transplantation for hepatitis B-related liver disease without hepatitis B immune globulin prophylaxis.
Topics: Adenine; Adolescent; Adult; Aged; Antiviral Agents; DNA, Viral; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Immunosuppression Therapy; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Living Donors; Male; Middle Aged; Organophosphonates; Prospective Studies; Recurrence; Tenofovir; Treatment Outcome | 2013 |
WHO survey finds half of countries do not have clinical guidelines for treating hepatitis.
Topics: Adenine; Antiviral Agents; Drugs, Essential; Global Health; Guanine; Health Priorities; Hepatitis B; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Organophosphonates; Polyethylene Glycols; Practice Guidelines as Topic; Recombinant Proteins; Tenofovir; World Health Organization | 2013 |
HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes.
Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cohort Studies; Coinfection; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Prospective Studies; Reverse Transcriptase Inhibitors; South Africa; Tenofovir; Treatment Outcome; Zambia | 2013 |
HBV clinical isolates expressing adefovir resistance mutations show similar tenofovir susceptibilities across genotypes B, C and D.
Topics: Adenine; Base Sequence; Cloning, Molecular; DNA Primers; Drug Resistance, Viral; Genotype; Hepatitis B; Hepatitis B virus; Humans; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation, Missense; Organophosphonates; Sequence Analysis, DNA; Tenofovir | 2014 |
Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection.
Topics: Adenine; Antiviral Agents; Biomarkers; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Immunization Schedule; Immunoglobulins; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Retrospective Studies; Tenofovir; Time Factors; Treatment Outcome; Turkey; Viral Load | 2013 |
Lamivudine compared with newer antivirals for prophylaxis of hepatitis B core antibody positive livers: a cost-effectiveness analysis.
Topics: Adenine; Antiviral Agents; Cohort Studies; Cost-Benefit Analysis; Decision Trees; Follow-Up Studies; Graft Survival; Guanine; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Markov Chains; Organophosphonates; Prognosis; Quality-Adjusted Life Years; Survival Rate; Tenofovir | 2014 |
Incidence and risk factors for incomplete HBV DNA suppression in HIV/HBV-co-infected patients initiating tenofovir-based therapy.
Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cohort Studies; Coinfection; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Incidence; Lamivudine; Male; Middle Aged; Organophosphonates; Retrospective Studies; Risk Factors; Tenofovir; Viral Load; Viremia | 2014 |
Clinical problem-solving. Wasting away.
Topics: Adenine; Adult; Bone Diseases, Metabolic; Cachexia; Diagnosis, Differential; Fanconi Syndrome; Female; Hepatitis B; Humans; Hypophosphatemia; Liver Function Tests; Organophosphonates; Pelvic Bones; Phosphates; Radiography; Reverse Transcriptase Inhibitors; Tenofovir | 2014 |
Virologic and serologic outcomes of mono versus dual HBV therapy and characterization of HIV/HBV coinfection in a US cohort.
Topics: Adenine; Adult; Antibodies, Viral; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; Coinfection; Deoxycytidine; DNA, Viral; Emtricitabine; Female; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; HIV Infections; Humans; Lamivudine; Logistic Models; Male; Middle Aged; Organophosphonates; Randomized Controlled Trials as Topic; Retrospective Studies; Tenofovir; United States | 2014 |
Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus.
Topics: Adenine; Adult; Antiviral Agents; Cohort Studies; Female; Gastrointestinal Diseases; Hepatitis B; Hepatitis B virus; Humans; Incidence; Lamivudine; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prospective Studies; Tenofovir; Time Factors; Treatment Outcome; Viral Load | 2014 |
Tenofovir disoproxil fumarate rescue therapy for HBV recurrence in two liver transplant recipients with previous multiple nucleo(s/t)ide treatment failures.
Topics: Adenine; Aged; Follow-Up Studies; Graft Rejection; Graft Survival; Hepatitis B; Humans; Liver Failure; Liver Function Tests; Liver Transplantation; Male; Nucleotides; Organophosphonates; Recurrence; Retreatment; Risk Assessment; Tenofovir; Transplant Recipients; Treatment Failure; Treatment Outcome | 2014 |
An HBV-HIV co-infected patient treated with tenofovir-based therapy who achieved HBs antigen/antibody seroconversion.
Topics: Adenine; Adolescent; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Coinfection; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; HIV Infections; Humans; Male; Organophosphonates; Tenofovir | 2014 |
The role of tenofovir in preventing and treating hepatitis B virus (HBV) reactivation in immunosuppressed patients. A real life experience from a tertiary center.
Topics: Adenine; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; Female; Hepatitis B; Humans; Immunocompromised Host; Immunologic Factors; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Organophosphonates; Rituximab; Tenofovir; Virus Activation | 2014 |
First report of successful clearance of hepatitis B and D coinfection with tenofovir monotherapy.
Topics: Adenine; Adult; Coinfection; Hepatitis B; Hepatitis D; Humans; Male; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir | 2015 |
Postexposure prophylactic effect of hepatitis B virus (HBV)-active antiretroviral therapy against HBV infection.
Topics: Adenine; Animals; Antiviral Agents; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mice; Organophosphonates; Retrospective Studies; Tenofovir | 2015 |
The kinetics of the hepatitis B surface antigen level after the initiation of antiretroviral therapy for hepatitis B virus and human immunodeficiency virus coinfected patients.
Topics: Adult; Anti-Retroviral Agents; Coinfection; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Kinetics; Male; Middle Aged; Retrospective Studies; RNA, Viral; Tenofovir; Viral Load; Young Adult | 2015 |
The efficacy and safety of tenofovir in the prevention of hepatitis B virus recurrence following liver transplantation.
Topics: Adenine; Antiviral Agents; End Stage Liver Disease; Female; Hepatitis B; Humans; Immunoglobulins; Liver Transplantation; Male; Middle Aged; Organophosphonates; Postoperative Complications; Recurrence; Retrospective Studies; Tenofovir; Treatment Outcome | 2014 |
Low-dose short-term hepatitis B immunoglobulin with high genetic barrier antivirals: the ideal post-transplant hepatitis B virus prophylaxis?
Topics: Adenine; Adult; Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Drug Resistance, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Prospective Studies; Recurrence; Tenofovir | 2015 |
Limited hepatitis B immunoglobulin with potent nucleos(t)ide analogue is a cost-effective prophylaxis against hepatitis B virus after liver transplantation.
Topics: Adenine; Adult; Aged; Antiviral Agents; Cost-Benefit Analysis; Drug Costs; Female; Graft Survival; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immunoglobulins; Liver Transplantation; Male; Middle Aged; Organophosphonates; Retrospective Studies; Tenofovir; Treatment Outcome; United States | 2015 |
Dramatic Improvement of Chronic Inflammatory Demyelinating Polyneuropathy Through Tenofovir Treatment in a Patient Infected with Hepatitis B Virus.
Topics: Adult; Antiviral Agents; Hepatitis B; Hepatitis B virus; Humans; Male; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Tenofovir; Treatment Outcome | 2015 |
Efficacy and safety of lamivudine or tenofovir plus intramuscular hepatitis B immunoglobulin in prevention of hepatitis B virus reinfection after liver transplant.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Injections, Intramuscular; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Prospective Studies; Recurrence; Tenofovir; Time Factors; Treatment Outcome; Virus Activation; Young Adult | 2015 |
Nucleoside-Nucleotide Analog Combination Therapy Is Effective in Preventing Recurrent Hepatitis B After Liver Transplantation.
Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Prospective Studies; Recurrence; Tenofovir | 2015 |
A LC-MS method to quantify tenofovir urinary concentrations in treated patients.
Topics: Antiretroviral Therapy, Highly Active; Calibration; Chromatography; Chromatography, Liquid; Drug Monitoring; Hepatitis B; HIV Infections; Humans; Limit of Detection; Mass Spectrometry; Reproducibility of Results; Tenofovir; United States; United States Food and Drug Administration; Urinalysis | 2015 |
Tenofovir-best hope for treatment of chronic hepatitis B infection?
Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Antiviral Agents; Carcinoma, Hepatocellular; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Seroconversion; Tenofovir; Treatment Outcome; Young Adult | 2015 |
Tenofovir-based antiretroviral therapy in
HBV-HIV coinfection: results from the TREAT Asia HIV Observational Database.
Topics: Antiretroviral Therapy, Highly Active; Antiviral Agents; Biomarkers; CD4 Lymphocyte Count; Cohort Studies; Coinfection; Databases, Factual; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Kidney Function Tests; Liver Function Tests; Male; Mortality; Reverse Transcriptase Inhibitors; Risk Factors; Tenofovir; Treatment Outcome | 2016 |
HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons.
Topics: Adult; Aged; Antiviral Agents; Coinfection; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Retrospective Studies; Switzerland; Tenofovir; Viral Load; Young Adult | 2015 |
Efficacy of tenofovir disoproxil fumarate to prevent vertical transmission in mothers with lamivudine-resistant HBV.
Topics: Adult; Antiviral Agents; Biomarkers; Drug Resistance, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Male; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Treatment Outcome; Viral Load; Virus Replication | 2015 |
Tenofovir disoproxil treatment for a HIV-hepatitis B virus coinfected patient undergoing peritoneal dialysis: which dose do we need?
Topics: Antiviral Agents; Coinfection; Hemodialysis Solutions; Hepatitis B; HIV Infections; Humans; Peritoneal Dialysis; Renal Insufficiency; Serum; Tenofovir | 2015 |
Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan Africa.
Topics: Africa; Antiviral Agents; Biomarkers; Cohort Studies; Coinfection; Drug Therapy, Combination; Emtricitabine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; HIV Infections; Humans; Lamivudine; Predictive Value of Tests; Prospective Studies; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Tenofovir; Time Factors | 2016 |
Mechanism of Adefovir, Tenofovir and Entecavir Resistance: Molecular Modeling Studies of How A Novel Anti-HBV Agent (FMCA) Can Overcome the Drug Resistance.
Topics: Adenine; Adenosine; Amino Acid Sequence; Antiviral Agents; Binding Sites; Catalytic Domain; Databases, Protein; Drug Resistance, Viral; Gene Products, pol; Guanine; Hepatitis B; Hepatitis B virus; HIV Reverse Transcriptase; Humans; Hydrogen Bonding; Molecular Dynamics Simulation; Molecular Sequence Data; Mutation; Organophosphonates; Sequence Alignment; Tenofovir | 2015 |
Tenofovir-induced severe hepatitis in occult hepatitis B reactivation.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Chemical and Drug Induced Liver Injury; Cyclophosphamide; Doxorubicin; Hepatitis B; Hepatitis B virus; Humans; Immunocompromised Host; Liver Function Tests; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Rituximab; Tenofovir; Vincristine; Virus Activation | 2015 |
Hepatitis B Virus (HBV) Variants in Untreated and Tenofovir Treated Chronic Hepatitis B (CHB) Patients during Pregnancy and Post-Partum Follow-Up.
Topics: Adult; Antiviral Agents; Biomarkers; DNA, Viral; Female; Genome, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Tenofovir; Time Factors; Viral Load; Viral Proteins; Young Adult | 2015 |
Tenofovir monotherapy for hepatitis B after 1 year does not produce renal dysfunction, but is associated with hyperparathyroidism not related to vitamin D.
Topics: Adult; Albuminuria; Alkaline Phosphatase; Antiviral Agents; beta 2-Microglobulin; Creatinine; Cystatin C; Electrolytes; Female; Glomerular Filtration Rate; Hepatitis B; Humans; Hyperparathyroidism; Male; Middle Aged; Parathyroid Hormone; Renal Insufficiency; Serum Albumin; Tenofovir; Urea; Uric Acid; Vitamin D | 2016 |
Hepatitis B in rugby: is it time to revisit policy?
Topics: Antiviral Agents; Athletes; Football; Hepatitis B; Hepatitis B Vaccines; Humans; Male; Risk; Tenofovir | 2016 |
Effects of hepatitis B surface antigen (HBsAg) positivity of donors in HBsAg(+) renal transplant recipients: comparison of outcomes with HBsAg(+) and HBsAg(-) donors.
Topics: Adult; Antiviral Agents; Female; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Liver; Male; Middle Aged; Postoperative Complications; Tenofovir; Tissue Donors; Transplant Recipients | 2016 |
Lamivudine Monotherapy-Based cART Is Efficacious for HBV Treatment in HIV/HBV Coinfection When Baseline HBV DNA <20,000 IU/mL.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; China; Cohort Studies; Coinfection; DNA, Viral; Drug Therapy, Combination; Emtricitabine; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Prospective Studies; Tenofovir | 2016 |
Novel quantification of tenofovir disoproxil fumarate adherence in human immunodeficiency virus/hepatitis B coinfected patients with incomplete hepatitis B virus viral suppression.
Topics: Antiviral Agents; Coinfection; Defective Viruses; DNA, Viral; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; Humans; Tenofovir | 2016 |
[Novel therapeutic drugs GSK548470 (Tenofovir)].
Topics: Antiviral Agents; Clinical Trials, Phase III as Topic; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Tenofovir | 2015 |
Analysis of hepatitis B virus genotype changes in patients with chronic hepatitis B infection on tenofovir therapy.
Topics: Adolescent; Adult; Aged; Antiviral Agents; DNA, Viral; Female; Genetic Variation; Genotype; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Male; Middle Aged; Tenofovir; Young Adult | 2016 |
Dually Active HIV/HBV Antiretrovirals as Protection Against Incident Hepatitis B Infections: Potential for Prophylaxis.
Topics: Adult; Antiviral Agents; Chemoprevention; Emtricitabine; Female; Follow-Up Studies; Hepatitis B; HIV Infections; Humans; Lamivudine; Male; Prospective Studies; Tenofovir | 2016 |
Decay of ccc-DNA marks persistence of intrahepatic viral DNA synthesis under tenofovir in HIV-HBV co-infected patients.
Topics: Antiviral Agents; Coinfection; DNA, Circular; DNA, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; HIV Infections; Humans; Tenofovir | 2016 |
The hidden threat of hepatitis B.
Topics: Antiviral Agents; Disease Eradication; Hepatitis B; Humans; Mass Screening; Tenofovir; World Health Organization | 2016 |
Tenofovir for Prevention of Mother to Child Transmission of Hepatitis B, Evidence based Medicine Viewpoint.
Topics: Antiviral Agents; Child; Evidence-Based Medicine; Female; Hepatitis B; Hepatitis B virus; Humans; Infectious Disease Transmission, Vertical; Mothers; Pregnancy Complications, Infectious; Tenofovir | 2016 |
Tenofovir for Prevention of Mother to Child Transmission of Hepatitis B, Obstetricians Viewpoint.
Topics: Antiviral Agents; Child; Female; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Humans; Infectious Disease Transmission, Vertical; Mothers; Pregnancy Complications, Infectious; Tenofovir | 2016 |
Tenofovir for Prevention of Mother to Child Transmission of Hepatitis B,Neonatologists Viewpoint.
Topics: Antiviral Agents; Child; Female; Hepatitis B; Hepatitis B virus; Humans; Infectious Disease Transmission, Vertical; Mothers; Neonatologists; Pregnancy Complications, Infectious; Tenofovir | 2016 |
Renal function in HIV/HBV co-infected and HBV mono-infected patients on a long-term treatment with tenofovir in real life setting.
Topics: Adult; Antiviral Agents; Coinfection; Creatinine; Dose-Response Relationship, Drug; Female; Genotype; Glomerular Filtration Rate; Hepatitis B; HIV Infections; Humans; Kidney; Male; Middle Aged; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Tenofovir; Time Factors | 2017 |
Pre-exposure prophylaxis failure with tenofovir disoproxil.
Topics: Adult; Anti-HIV Agents; DNA, Viral; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Male; Pre-Exposure Prophylaxis; RNA, Viral; Syphilis; Tenofovir; Treatment Failure; Viral Load | 2017 |
Response to Tenofovir Among Lamivudine-experienced Hepatitis B and HIV-coinfected Adolescents.
Topics: Adolescent; Adult; Antiviral Agents; Child; Coinfection; DNA, Viral; Hepatitis B; HIV Infections; Humans; Lamivudine; Longitudinal Studies; Prospective Studies; Tenofovir; Young Adult | 2017 |
Tenofovir alafenamide demonstrates broad cross-genotype activity against wild-type HBV clinical isolates and maintains susceptibility to drug-resistant HBV isolates in vitro.
Topics: Adenine; Alanine; Antiviral Agents; Drug Resistance, Viral; Genotype; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Humans; Mutagenesis, Site-Directed; Phenotype; Prodrugs; Tenofovir; Virus Replication | 2017 |
Virological Response to Tenofovir Disoproxil Fumarate in HIV-Positive Patients with Lamivudine-Resistant Hepatitis B Virus Coinfection in an Area Hyperendemic for Hepatitis B Virus Infection.
Topics: Adult; Coinfection; Drug Combinations; Drug Resistance, Viral; Endemic Diseases; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Tenofovir; Treatment Outcome | 2016 |
Hepatitis B Leading to Megaloblastic Anemia and Catastrophic Peripheral Thrombocytopenia.
Topics: Adult; Anemia, Megaloblastic; Benzoates; Folic Acid; Folic Acid Deficiency; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Hydrazines; Male; Platelet Count; Polymerase Chain Reaction; Pyrazoles; Tenofovir; Thrombocytopenia; Vitamin B 12; Vitamin B 12 Deficiency; Vitamin B Complex | 2016 |
[Spontaneous remission of HCV infection after autologous stem cell transplantation in a 58-year-old man].
Topics: Antiviral Agents; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Male; Middle Aged; Multiple Myeloma; Remission, Spontaneous; Stem Cell Transplantation; Tenofovir; Virus Activation | 2017 |
Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations.
Topics: Adenine; Adult; Aged; Antiretroviral Therapy, Highly Active; Antiviral Agents; Cross-Sectional Studies; Drug Resistance, Viral; Female; Gene Products, pol; Genotype; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Polymerase Chain Reaction; Retrospective Studies; Tenofovir; Viral Load; Viremia | 2009 |
Long-term outcome of tenofovir disoproxil fumarate use against hepatitis B in an HIV-coinfected cohort.
Topics: Adenine; Adult; Antiviral Agents; Deoxycytidine; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; Female; Hepatitis B; Hepatitis B Antigens; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Organophosphonates; Retrospective Studies; Reverse Transcriptase Inhibitors; Tenofovir; Time Factors; Treatment Outcome; Virus Replication | 2009 |
Hepatitis B virus mutations potentially conferring adefovir/tenofovir resistance in treatment-naive patients.
Topics: Adenine; Adult; Amino Acid Substitution; Antiviral Agents; Drug Resistance, Viral; Genetic Variation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Tenofovir; Viral Proteins | 2009 |
The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen-positive and hepatitis B e antigen-negative hepatitis B virus strains.
Topics: Adenine; Anti-HIV Agents; Cell Line, Tumor; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Mutation; Nucleosides; Organophosphonates; Pyrimidinones; Telbivudine; Tenofovir; Thymidine; Viral Proteins; Virus Replication | 2009 |
Successful treatment of refractory Behçet's disease with the TNF-alpha blocker infliximab.
Topics: Adenine; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antiviral Agents; Behcet Syndrome; Hepatitis B; HLA-B Antigens; Humans; Infliximab; Male; Middle Aged; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; Tumor Necrosis Factor-alpha; Viral Load | 2009 |
Emergency transplantation for acute reactivation of chronic hepatitis B with high viral load: role of antiviral therapy.
Topics: Adenine; Blood Chemical Analysis; DNA, Viral; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Reverse Transcriptase Inhibitors; Secondary Prevention; Tenofovir; Ultrasonography; Viral Load | 2009 |
Reduced glomerular filtration rate but sustained virologic response in HIV/hepatitis B co-infected individuals on long-term tenofovir.
Topics: Adenine; Adult; Alanine Transaminase; Antiviral Agents; CD4 Lymphocyte Count; Cohort Studies; Female; Glomerular Filtration Rate; Hepatitis B; HIV Infections; Humans; Longitudinal Studies; Male; Middle Aged; Organophosphonates; Tenofovir; Treatment Outcome; Viral Load | 2009 |
[Failure to treat hepatitis B virus infection with adefovir due to early selection of rtA181T mutation].
Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B Antigens; Hepatitis B virus; Humans; Male; Middle Aged; Mutation; Organophosphonates; Phenotype; Tenofovir; Time Factors; Treatment Failure | 2010 |
High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy.
Topics: Adenine; Adult; Age Factors; Anti-HIV Agents; Anti-Retroviral Agents; Cameroon; Comorbidity; Female; Hepacivirus; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis C; Hepatitis C Antibodies; HIV Infections; HIV-1; Humans; Male; Middle Aged; Multivariate Analysis; Organophosphonates; Pregnancy; Retrospective Studies; Tenofovir; Transaminases | 2010 |
[Tenofovir, An antiviral agent with activity against HIV infections and hepatitis B].
Topics: Adenine; Anti-HIV Agents; Antiviral Agents; Hepatitis B; Hepatitis B virus; Humans; Organophosphonates; Patient Education as Topic; Tenofovir; Virus Replication | 2009 |
Resolution of chronic hepatitis Delta after 1 year of combined therapy with pegylated interferon, tenofovir and emtricitabine.
Topics: Adenine; Antibodies, Viral; Antiviral Agents; Deoxycytidine; DNA, Viral; Drug Therapy, Combination; Emtricitabine; Hepatitis B; Hepatitis D, Chronic; Hepatitis Delta Virus; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; RNA, Viral; Tenofovir; Treatment Outcome | 2010 |
Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues.
Topics: Adenine; Adolescent; Adult; Cohort Studies; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Retrospective Studies; Tenofovir; Treatment Outcome | 2010 |
[Protocol for the antiviral therapy of hepatitis B and D].
Topics: Adenine; Antiviral Agents; Biopsy; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis D; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Lamivudine; Liver Cirrhosis; Nucleotides; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; Tenofovir | 2010 |
Viral resistance in hepatitis B: prevalence and management.
Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Genetic Testing; Genotype; Guanine; Hepatitis B; Humans; Lamivudine; Nucleosides; Organophosphonates; Phenotype; Pyrimidinones; Telbivudine; Tenofovir; Thymidine | 2010 |
Drug therapy: tenofovir.
Topics: Adenine; Antiviral Agents; Female; Hepatitis B; Humans; Middle Aged; Organophosphonates; Tenofovir | 2010 |
Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy.
Topics: Adenine; Adult; Aged; Antiviral Agents; Asian People; DNA, Circular; DNA, Viral; Drug Resistance; Female; Gene Products, pol; Genetic Variation; Genome, Viral; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver; Liver Transplantation; Male; Middle Aged; Organophosphonates; Phylogeny; Tenofovir; Trans-Activators; Viral Envelope Proteins; Viral Regulatory and Accessory Proteins; Virus Replication | 2011 |
High frequency of lamivudine resistance mutations in Brazilian patients co-infected with HIV and hepatitis B.
Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Brazil; Comorbidity; Cross-Sectional Studies; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Mutation; Organophosphonates; Tenofovir; Viral Core Proteins; Viral Load; Viral Proteins | 2010 |
Efficacy and safety of entecavir and/or tenofovir for prophylaxis and treatment of hepatitis B recurrence post-liver transplant.
Topics: Adenine; Adult; Aged; Antiviral Agents; Combined Modality Therapy; Female; Guanine; Hepatitis B; Humans; Liver Transplantation; Male; Middle Aged; Organophosphonates; Secondary Prevention; Tenofovir | 2010 |
Entecavir as treatment for reactivation of hepatitis B in immunosuppressed patients.
Topics: Adenine; Aged; Antiviral Agents; Drug Therapy, Combination; Female; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Organophosphonates; Retrospective Studies; Tenofovir; Treatment Outcome | 2010 |
Prevention of lamivudine-resistant hepatitis B recurrence after liver transplantation with entecavir plus tenofovir combination therapy and perioperative hepatitis B immunoglobulin only.
Topics: Adenine; Antiviral Agents; Combined Modality Therapy; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Perioperative Care; Secondary Prevention; Tenofovir; Treatment Outcome | 2011 |
Low liver stiffness among cirrhotic patients with hepatitis B after prolonged treatment with nucleoside analogs.
Topics: Adenine; Adult; Elasticity Imaging Techniques; Female; Hepatitis B; Humans; Lamivudine; Liver; Liver Cirrhosis; Male; Middle Aged; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Time Factors | 2011 |
Successful tenofovir treatment for fulminant hepatitis B infection in an infant.
Topics: Adenine; Antiviral Agents; Female; Hepatitis B; Humans; Infant; Organophosphonates; Tenofovir; Treatment Outcome | 2011 |
Membranous nephropathy in an HIV-positive patient complicated with hepatitis B virus infection.
Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Deoxycytidine; Emtricitabine; Glomerulonephritis, Membranous; Hepatitis B; HIV Infections; Humans; Male; Nephrotic Syndrome; Organophosphonates; Prednisolone; Tenofovir | 2011 |
Late onset of hepatitis B virus reactivation following hematopoietic stem cell transplantation: successful treatment with combined entecavir plus tenofovir therapy.
Topics: Adenine; Age of Onset; Antiviral Agents; Drug Therapy, Combination; Female; Guanine; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B virus; Humans; Middle Aged; Organophosphonates; Tenofovir; Transplantation, Homologous; Treatment Outcome; Virus Activation | 2012 |
Design, synthesis, and biological evaluation of triazolo-pyrimidine derivatives as novel inhibitors of hepatitis B virus surface antigen (HBsAg) secretion.
Topics: Adenine; Animals; Antiviral Agents; Biological Availability; Drug Design; Drug Resistance, Viral; Guanine; Hep G2 Cells; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Mice; Models, Chemical; Molecular Structure; Mutation; Organophosphonates; Pyrimidines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Tenofovir; Tetrazoles | 2011 |
HIV-HBV vaccine escape mutant infection with loss of HBV surface antibody and persistent HBV viremia on tenofovir/emtricitabine without antiviral resistance.
Topics: Adenine; Antiviral Agents; Coinfection; Deoxycytidine; Drug Resistance, Viral; Emtricitabine; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; HIV Infections; HIV-1; Humans; Male; Middle Aged; Mutation; Organophosphonates; Tenofovir; Viral Load; Viremia | 2011 |
Long-term outcome of primary non-responders to tenofovir therapy in HIV/HBV-co-infected patients: impact of HBV genotype G.
Topics: Adenine; Adult; Anti-HIV Agents; Coinfection; Deoxycytidine; DNA Mutational Analysis; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; Female; Genotype; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Retrospective Studies; Tenofovir; Time Factors; Treatment Outcome | 2012 |
Comparison between Elecsys HBsAg II and architect HBsAg QT assays for quantification of hepatitis B surface antigen among patients coinfected with HIV and hepatitis B virus.
Topics: Adenine; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Coinfection; Female; Genotype; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; Humans; Male; Middle Aged; Organophosphonates; Reagent Kits, Diagnostic; Tenofovir | 2012 |
Substitution of tenofovir/emtricitabine for Hepatitis B immune globulin prevents recurrence of Hepatitis B after liver transplantation.
Topics: Adenine; Adult; Antiviral Agents; Deoxycytidine; Emtricitabine; Female; Hepatitis B; Humans; Immunoglobulins; Liver Transplantation; Male; Middle Aged; Organophosphonates; Secondary Prevention; Tenofovir | 2012 |
Severe vitamin D deficiency in a patient treated for hepatitis B with tenofovir.
Topics: Adenine; Hepatitis B; Humans; Hypophosphatemia; Male; Middle Aged; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Vitamin D Deficiency | 2012 |
[Hungarian consensus guideline for the diagnosis and treatment of B, C, and D viral hepatitis].
Topics: Adenine; Antiviral Agents; Comorbidity; Consensus; Drug Administration Schedule; Drug Therapy, Combination; Genotype; Guanine; Hepacivirus; Hepatitis B; Hepatitis C; Hepatitis D; Humans; Hungary; Interferon-alpha; Interferons; Lamivudine; Oligopeptides; Organophosphonates; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; RNA, Viral; Tenofovir; Time Factors; Treatment Outcome | 2012 |
Hepatitis B prophylaxis post liver transplantation with newer nucleos(t)ide analogues after hepatitis B immunoglobulin discontinuation.
Topics: Adenine; Adult; Aged; Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Guanine; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Nucleotides; Organophosphonates; Secondary Prevention; Tenofovir; Treatment Outcome; Young Adult | 2012 |
Five-year review of HIV-hepatitis B virus (HBV) co-infected patients in a New York City AIDS center.
Topics: Adenine; Adult; Anti-HIV Agents; Coinfection; Female; Hepatitis B; Hepatitis B e Antigens; HIV Infections; Humans; Liver Cirrhosis; Male; Middle Aged; New York City; Organophosphonates; Retrospective Studies; Tenofovir | 2012 |
Evolution of adefovir-resistant HBV polymerase gene variants after switching to tenofovir disoproxil fumarate monotherapy.
Topics: Adenine; Adult; Aged; Antiviral Agents; Cloning, Molecular; DNA, Viral; Drug Resistance, Viral; Drug Substitution; Escherichia coli; Evolution, Molecular; Female; Follow-Up Studies; Gene Products, pol; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Tenofovir; Viremia | 2012 |
Does interferon-sparing tenofovir disoproxil fumarate-based therapy have a role in the management of severe acute hepatitis delta superinfection?
Topics: Acute Disease; Adenine; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis D; Hepatitis Delta Virus; Humans; Interferons; Lamivudine; Male; Organophosphonates; RNA, Viral; Superinfection; Tenofovir; Young Adult | 2012 |
Evaluation of single and combination therapies with tenofovir disoproxil fumarate and emtricitabine in vitro and in a robust mouse model supporting high levels of hepatitis B virus replication.
Topics: Adenine; Animals; Antiviral Agents; Cell Line; Deoxycytidine; Drug Combinations; Drug Interactions; Emtricitabine; Hepatitis B; Hepatitis B virus; Mice; Mice, Nude; Organophosphonates; Phosphorylation; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Tenofovir; Viremia; Virus Replication | 2012 |
Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir + emtricitabine-based HAART in HBV-HIV-coinfected patients.
Topics: Adenine; Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Coinfection; Deoxycytidine; Emtricitabine; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Organophosphonates; Retrospective Studies; Tenofovir; Treatment Outcome; Viral Load; Virus Replication | 2012 |
Blunted fetal growth by tenofovir in late pregnancy.
Topics: Adenine; Adult; Anti-HIV Agents; Asian People; Bone Density; Female; Fetal Growth Retardation; Hepatitis B; HIV Seropositivity; Humans; Infant, Newborn; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Tenofovir | 2012 |
Severe acute hepatitis B in a treatment-naïve patient with antiviral drug resistant mutations in the polymerase gene.
Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Genotype; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Italy; Lamivudine; Male; Middle Aged; Mutation, Missense; Organophosphonates; Telbivudine; Tenofovir; Thailand; Thymidine; Travel; Treatment Outcome | 2013 |
The amino acid substitutions rtP177G and rtF249A in the reverse transcriptase domain of hepatitis B virus polymerase reduce the susceptibility to tenofovir.
Topics: Adenine; Amino Acid Substitution; Animals; Antiviral Agents; Computational Biology; Disease Models, Animal; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mutagenesis, Site-Directed; Mutant Proteins; Organophosphonates; RNA-Directed DNA Polymerase; Tenofovir | 2013 |
Reactivation of occult hepatitis B virus infection following cytotoxic lymphoma therapy in an anti-HBc negative patient.
Topics: Adenine; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antiviral Agents; DNA, Viral; Genotype; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunologic Factors; Lymphoma; Male; Organophosphonates; Papua New Guinea; Phylogeny; Rituximab; Sequence Analysis, DNA; Tenofovir; Viral Load; Virus Activation | 2013 |
Sexually transmitted infection with an immune-escape mutant hepatitis B virus in an hepatitis B virus-vaccinated individual with acute HIV-hepatitis C virus infection.
Topics: Acute Disease; Adenine; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Darunavir; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis C; HIV Seropositivity; Homosexuality, Male; Humans; Male; Organophosphonates; Sulfonamides; Tenofovir; Treatment Outcome; Unsafe Sex; Viral Load | 2013 |
Efficacy of combined antiviral therapy with lamivudine and tenofovir in a liver transplanted girl with de novo hepatitis B virus infection.
Topics: Adenine; Antiviral Agents; Child, Preschool; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Organophosphonates; Tenofovir; Treatment Outcome | 2013 |
Tenofovir treatment in patients with lamivudine-resistant hepatitis B mutants strongly affects viral replication.
Topics: Adenine; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Organophosphonates; Organophosphorus Compounds; Reverse Transcriptase Inhibitors; Tenofovir; Virus Replication | 2002 |
Editorial comment: a tale of two viruses.
Topics: Adenine; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B Vaccines; HIV Infections; Humans; Lamivudine; Organophosphonates; Organophosphorus Compounds; Reverse Transcriptase Inhibitors; Tenofovir | 2002 |
Tenofovir disoproxil fumarate in patients with HIV and lamivudine-resistant hepatitis B virus.
Topics: Adenine; Adult; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Tenofovir | 2003 |
Tenofovir disoproxil fumarate exhibits strong antiviral effect in a patient with lamivudine-resistant severe hepatitis B reactivation.
Topics: Adenine; Antiviral Agents; Drug Resistance, Microbial; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Recurrence; Reverse Transcriptase Inhibitors; Tenofovir; Virus Activation | 2003 |
Tenofovir helps beat hepatitis B.
Topics: Adenine; Antiviral Agents; CD4 Lymphocyte Count; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Male; Organophosphonates; Organophosphorus Compounds; Tenofovir; Viral Load | 2003 |
Antiviral Research--16th Annual International Conference. Satellite symposium: clinical update on antiviral drugs. 27 April-1 May 2003, Savannah, GA, USA.
Topics: Adenine; Anti-HIV Agents; Antiviral Agents; Clinical Trials as Topic; Enfuvirtide; Ganciclovir; Hepatitis B; HIV Envelope Protein gp41; HIV Infections; Humans; Organophosphonates; Organophosphorus Compounds; Peptide Fragments; Tenofovir; Valganciclovir | 2003 |
Antiretroviral therapy and HIV/hepatitis B virus coinfection.
Topics: Adenine; Antiretroviral Therapy, Highly Active; Antiviral Agents; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Lamivudine; Organophosphonates; Organophosphorus Compounds; Tenofovir | 2004 |
In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
Topics: Adenine; Adult; Antiviral Agents; Cell Line; DNA-Directed DNA Polymerase; DNA, Viral; Dose-Response Relationship, Drug; Drug Resistance, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Middle Aged; Mutation; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Transfection; Virus Replication | 2004 |
Tenofovir therapy for lamivudine resistance following liver transplantation.
Topics: Adenine; Adult; Antiviral Agents; Chronic Disease; Drug Resistance, Viral; Hepatitis B; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Organophosphonates; Retrospective Studies; Salvage Therapy; Tenofovir; Treatment Outcome | 2004 |
Successful therapy of hepatitis B with tenofovir in HIV-infected patients failing previous adefovir and lamivudine treatment.
Topics: Adenine; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Chronic Disease; DNA-Directed DNA Polymerase; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Mutation; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; Viral Load | 2004 |
Tenofovir helpful for patients with HBV.
Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Hepatitis B; HIV Infections; Humans; Organophosphonates; Randomized Controlled Trials as Topic; Tenofovir | 2005 |
Successful treatment with tenofovir in a child C cirrhotic patient with lamivudine-resistant hepatitis B virus awaiting liver transplantation. Post-transplant results.
Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Mutation; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; Waiting Lists | 2005 |
Reactivation of viral replication after replacement of tenofovir by adefovir.
Topics: Adenine; Adult; Antiviral Agents; Hepatitis B; Humans; Male; Middle Aged; Organophosphonates; Tenofovir; Treatment Failure; Treatment Outcome; Virus Activation | 2005 |
Wild type and YMDD variant of hepatitis B virus: no difference in viral kinetics on lamivudine/tenofovir therapy in HIV-HBV co-infected patients.
Topics: Adenine; Adult; Anti-HIV Agents; DNA, Viral; Drug Resistance, Viral; Genetic Variation; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Kinetics; Lamivudine; Male; Middle Aged; Organophosphonates; RNA, Viral; Tenofovir | 2006 |
Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients.
Topics: Adenine; Adult; Antiviral Agents; Cohort Studies; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Retrospective Studies; Tenofovir; Treatment Outcome | 2006 |
Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy.
Topics: Adenine; Adult; Disease Progression; DNA, Viral; Drug Resistance, Viral; Female; Follow-Up Studies; Gene Products, pol; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Retrospective Studies; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; Virus Replication | 2006 |
Hepatitis delta virus super-infection in a co-infected patient with the human immunodeficiency virus type 1 and a surface antigen-negative hepatitis B virus variant.
Topics: Adenine; Alanine Transaminase; Amino Acid Sequence; Anti-HIV Agents; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Hepatitis D; HIV Infections; HIV-1; Homosexuality, Male; Humans; Male; Middle Aged; Molecular Sequence Data; Organophosphonates; RNA, Viral; Superinfection; Tenofovir; Time Factors; Viral Load | 2006 |
Aminotransferase elevation in HIV/hepatitis B virus co-infected patients treated with two active hepatitis B virus drugs.
Topics: Adenine; Adult; Antiretroviral Therapy, Highly Active; DNA, Viral; Female; Hepatitis B; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Tenofovir; Transaminases | 2006 |
Antiviral therapy for pre- and post-liver transplantation patients with hepatitis B.
Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Guanine; Hepatitis B; Hepatitis B virus; Humans; Kidney Diseases; Lamivudine; Liver Transplantation; Organophosphonates; Secondary Prevention; Tenofovir | 2007 |
Response to Schmutz et al., 'Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection'.
Topics: Adenine; Drug Therapy, Combination; Hepatitis B; HIV Infections; Humans; Lamivudine; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Failure | 2007 |
Improvements in parameters of end-stage liver disease in patients with HIV/HBV-related cirrhosis treated with tenofovir.
Topics: Adenine; CD4 Lymphocyte Count; DNA, Viral; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; HIV Infections; Humans; Liver Cirrhosis; Liver Failure; Male; Middle Aged; Organophosphonates; Reverse Transcriptase Inhibitors; Severity of Illness Index; Tenofovir; Time Factors; Treatment Outcome; Viral Load | 2007 |
Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons.
Topics: Adenine; Adult; Alanine Transaminase; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Biomarkers; Carrier State; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cohort Studies; DNA, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; London; Male; Organophosphonates; Prevalence; Tenofovir | 2007 |
Development of a novel mouse model to evaluate drug candidates against hepatitis B virus.
Topics: Adenine; Animals; Antiviral Agents; Cell Line; Disease Models, Animal; Drug Evaluation, Preclinical; Hepatitis B; Hepatitis B virus; Lamivudine; Mice; Mice, Nude; Organophosphonates; Reproducibility of Results; Tenofovir | 2007 |
Potency of tenofovir in chronic hepatitis B: mono or combination therapy?
Topics: Adenine; Antiviral Agents; Deoxycytidine; DNA, Viral; Drug Therapy, Combination; Emtricitabine; Guanine; Hepatitis B; Hepatitis B, Chronic; Humans; Lamivudine; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; Viral Load | 2008 |